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CO-MORBID SYMPTOMS OF DEPRESSION AND ANXIETY AND BIO-
BEHAVIORAL RESPONSE TO STRESS IN PATIENTS WITH HEART FAILURE 
 
Heart failure (HF) is a major public health problem throughout the world. It 
accounts for one death certificate among nine in the United States. Heart failure and 
sudden death combined are responsible for the largest number of deaths in America. The 
total costs of HF in the United States are estimated to be $37 billion each year. Despite 
substantial medical and surgical advances related to treatment of HF, it remains a very 
costly condition with high mortality and morbidity rates. Although biological factors 
contribute to high morbidity and mortality in HF, there are many unexplored 
psychosocial factors that also likely contribute to these rates. Thus, the purpose of this 
dissertation was to examine the association between some of the psychosocial factors (i.e. 
depression, anxiety, comorbid depression and anxiety, stress, cognitive appraisal, and 
coping) and health outcomes as defined by rehospitalisation and mortality among HF 
patients.  
 
The first paper is a report of longitudinal study of 1,260 patients with HF. The 
purpose of the study was to determine whether co-morbid symptoms of depression and 
anxiety are associated with all-cause mortality or rehospitalization for cardiac causes in 
patients with HF. Anxiety and depression were treated first as continuous level variables, 
then as categorical variables using standard published cut points. Patients were then 
divided into four groups based on the presence of symptoms of anxiety and depression. 
When depression and anxiety were treated as continuous level variables, both comorbid 
depression and anxiety, and depression alone were significant predictors of all-cause 
mortality. However, when depression and anxiety were treated as categorical variables, 
comorbid depression and anxiety was a predictor of all-cause mortality, while anxiety 
and depressive symptoms considered alone were not independent predictors of the same 
outcome. None of those variables were significant predictors of cardiac rehospitalization 
outcome, regardless of whether entered as continuous or categorical level variables. 
 
The second paper is a report of a study that was conducted to (1) examine the 
association of stress with 6-month cardiac event-free survival; (2) examine the 
relationship of stress with salivary cortisol; and (3) examine the association of salivary 
cortisol level with 6-month cardiac event-free survival. The study sample was 81 HF 
patients. A prospective design was used in which patients were followed for 6 months to 
determine occurrence of 6-month cardiac event-free survival, defined as time to the 
 
 
combined endpoint of cardiac rehospitalization or all-cause death. Stress was not a 
significant predictor of event-free survival in HF, salivary cortisol was a significant 
predictor of event-free survival in the unadjusted model, but not in the adjusted model, 
and stress was not a significant predictor of salivary cortisol level. 
 
The final paper is a report of prospective design study that aimed to describe self-
reported stress level, cognitive appraisal and coping among patients with HF, and to 
examine the association of cognitive appraisal and coping strategies with event-free 
survival based on a proposed model of HF patients’ response to stressors that been 
suggested according to literature to date. The study sample consisted of 88 HF patients 
who been followed for 6 months to determine occurrence of the combined endpoint of 
rehospitalization for cardiac causes or all-cause death. The study showed that stress level 
was associated with harm and loss cognitive appraisal. Harm/loss and threat cognitive 
appraisals were associated with avoidant emotional coping. Furthermore, harm/loss 
cognitive appraisal was a significant predictor of avoidant emotional coping and event 
free survival.  Finally avoidant emotional coping was a significant predictor of event free 
survival among HF patients in the unadjusted model, but not in the adjusted model. 
 
The findings from this dissertation provided further evidence of the importance of 
psychosocial factors to health outcomes in HF patients. It also filled important gaps in the 
body of knowledge related to health outcomes among those with HF by demonstrating 
the need for cognitive and behavioral therapy among HF patients who negatively appraise 
their health condition.  
 
Keywords: Heart failure, Comorbid depression and anxiety, Stress, Health outcomes, 
Cognitive appraisal and Coping. 
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CHAPTER ONE 
 
Introduction 
 
Heart failure (HF) is a complex, progressive clinical condition arising from any 
structural or functional cardiac disorder that affects the capability of cardiac ventricles to 
fill with or eject blood.1 In the United States, HF is considered a major public health 
problem that affects around 5.7 million patients, with 670,000 newly diagnosed patients 
each year.2,3 Heart failure and sudden death combined are responsible for the largest 
number of deaths in America.4,5 The total costs of HF in the United States are estimated 
to be $37 billion each year, and this number will rise to around $70 billion by 2030.2,6 By 
2030, more than 8 million people in the United States will be diagnosed with HF.6 
Despite substantial medical and surgical advances related to treatment of HF, in 2010, 
there were about 279 000 deaths related to HF, which is as high as that reported in 1995 
(287 000).3 Heart failure also is the most common hospital discharge diagnosis among 
elders and the number of hospitalizations for HF is increasing substantially each year.3,4  
The one-year mortality rate of HF patients with progressive symptoms still 
approaches 40%, which is the same for some types of aggressive cancer.7,8 Even patients 
who have less serious HF symptoms usually experience impaired quality of life.8 The 
high mortality and morbidity rates associated with HF are still not well explained. 9 
Although biological factors explain some aspects of the high mortality and 
rehospitalization rates, it would not be surprising if other aspects of  these rates are 
related to psychological factors such as depression, anxiety, and stress.9  Patients with HF 
concurrently suffer from multiple psychological symptoms that affect patients’ prognosis, 
physical health, and mental well-being such as symptoms of depression and anxiety. 
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Furthermore, HF is generally perceived as a very stressful experience that also likely 
contributes to the poor prognosis. 9-15 
Depression is a mood disorder that affect the patient’s capability to deal with 
daily life activities.16,17 Depression is associated with distinct symptoms such as changes 
in appetite, sleep disturbance, fatigue, agitation, feelings of guilt or worthlessness, and 
concentration problems.11,18,19 In the context of HF, depression  is considered a major 
clinical problem that affects around 48% of the outpatients who have HF with up to 20% 
of those are experiencing major depression symptoms.20 Heart failure patients who suffer 
from depressive symptoms have two times the risk of being rehospitalized or dying 
compared to those who do not suffer from these symptoms.21 Furthermore, patients who 
suffer from depressive symptoms often engage in unhealthy behaviors like smoking, 
excess alcohol use, drug use, and unsatisfactory adherence. 22,23 Pathophysiologically, 
depression is associated with negative effects on cardiac function through mechanisms 
such as hypercortisolemia, impaired platelet function, and reduced heart rate variability. 
24-27  
When the individual is unable to predict, control, or even gain from a situation 
that is perceived by the individual as a threat, this will lead to a state of negative emotions 
called anxiety. 11,16 Like depression, anxiety is also associated with negative cardiac 
events such as coronary artery diseases and sudden cardiac death. 10,16 Anxiety also may 
be considered a mediator for some pathophysiological mechanisms that affect health 
outcomes such as cardiac arrhythmias, reduced heart rate variability, and baroreflex 
cardiac control. 28-30 Anxiety is considered a major clinical problem that affects 40% of 
HF Patients with a severity that is 60% higher than anxiety severity in healthy elders. 
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11,31,32 Furthermore, anxiety severity in patients with HF tends to be higher than among 
patients with other cardiac, lung, and cancer diseases. 33,34 Conversely, there are 
contradictory results about the effect of anxiety on health outcomes among patients with 
HF.33,34  
Multiple studies addressed the association of depression and anxiety, individually, 
with survival in HF patients; however, the association between co-morbid symptoms of 
anxiety and depression and survival is unknown. Thus, Chapter Two of this dissertation 
is a report of a study in which we investigated the association of co-morbid symptoms of 
depression and anxiety with all-cause mortality and cardiac rehospitalization in patients 
with HF. Chapter Two presents a secondary analysis from a longitudinal study of 1,260 
patients with HF. The purpose of the study was to determine whether co-morbid 
symptoms of depression and anxiety are associated with all-cause mortality or 
rehospitalization for cardiac causes in patients with HF. Cox regression analysis was used 
to determine whether co-morbid symptoms of depression and anxiety independently 
predicted all-cause mortality and cardiac rehospitalization. The results showed that the 
interaction between symptoms of depression and anxiety (when the variable was 
considered at the continuous level) was a significant predictor of all-cause mortality but 
not cardiac hospitalization. In addition, comorbid depression and anxiety when the 
variable was considered at the categorical level was a significant predictor for all-cause 
mortality but not cardiac rehospitalization (versus no symptoms, or symptoms of anxiety 
or depression alone).   Questions remaining are, (1) what factors lead to symptoms of 
depression and anxiety in patients with HF? And (2) why do HF patients suffer from 
depression and anxiety more than other populations?  
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Depression or anxiety symptoms often develop after stressful life events that are 
not cognitively processed in a healthy manner.35  Thus, cognitive appraisal of the 
stressful events plays a major role in selecting a suitable coping strategy to handle 
stressful events.36 Therefore, although stressful events play an integral role in producing 
symptoms of depression and anxiety, there are individual variances in how people 
respond to these events.36 In a classic study conducted by Brown & Harris (1978)37, 
stressful events rapidly led to depression within the first month after the event.37 Other 
studies suggest that stressful events may cause depletion of several neurotransmitters 
such as norepinephrine, dopamine, and serotonin, which may lead to depression or 
anxiety symptoms.38  
In a study conducted among Mexican-American college students, higher levels of 
stress were associated with higher levels of depression and anxiety symptoms.39 
Furthermore, coping mechanisms were predictors of depression and anxiety symptoms.39 
A study in which investigators studied the moderating effects of gender and cognitive 
avoidance coping on the negative life events–depressive/anxious symptoms relationship 
demonstrated that stressful life events predicted symptoms of depression and anxiety.40 In 
addition, cognitive coping strategies were predictors of depression and anxiety symptoms 
in a study that investigated healthy adolescents and adults.41  
Depression and anxiety symptoms are been well studied in HF population. 
However, there is limited information about the effect of stress and coping mechanisms 
in HF population. Thus, there is a need to establish a body of knowledge regarding stress 
and coping mechanisms in the HF population, so it can be used by both clinicians and 
researchers to decrease the high mortality and rehospitalization rates in HF patients. To 
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fully understand stress and coping in HF context, some of the concepts need to be defined 
in this chapter. 
Stressors can be defined as environmental events or chronic conditions that 
objectively threaten the physical and/or psychological health or well-being of 
individuals.42 Stressors may lead to a state in which a patient perceives that 
environmental demands exceed his or her adaptive capacity 43; this state is called stress. 
The term “stress” also can be used to summarize the effects of psychological and 
environmental factors on the patient’s physical and mental health. 44,45 Stressful events 
are unpredictable and seemingly uncontrollable events that affect individuals’ lives. 
Given that HF is associated with many of the psychological distress factors that 
significantly affect patients’ prognosis, physical health, and mental well-being, HF is a 
very stressful experience physically and psychologically.11,12 11,12  
There is limited information about stress and heart failure. However, in cardiac 
disease patients, stress was associated with multiple adverse effects on patient health 
outcomes.46-48 For example, stress was associated with decreased blood supply to the 
coronary arteries and was a significant predictor of greater severity of cardiac disease.49,50 
In addition, a lower level of stress was a predictor of improved prognosis and cardiac 
function in cardiac disease patients.51 Furthermore, stress had an effect on the immune 
system which may exacerbate disease processes and lead to further complications.52 
Finally, stress was significantly associated with an increased mortality rate among cardiac 
disease patients.53 
Stress is defined physiologically as the condition  in which the 
sympathoadrenomedullary system  (SAM) and the limbic-hypothalamic-pituitary-adrenal 
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axis (HPA) are co-activated.54 Stressors mainly activate two major neural pathways 
which are the HPA axis and the sympathetic nervous system. The activation of the 
sympathoadrenomedullary system is the initial and rapid acting response of the body to 
stress. However, HPA axis activation is the delayed body response to stress to restore 
homeostasis. 55   
The SAM system is activated through the hypothalamus and brain stem, which 
sends an activation signal to the adrenal medulla that releases stored epinephrine into the  
blood circulation.  The release of epinephrine will promote changes in the tissues that 
supplied by beta-adrenoreceptors such as cardiac, blood vessels, liver, adipose tissues and 
musculoskeletal. 56 The activation of beta-adrenoreceptors promote changes such as 
increased heart rate and contractility, vasodilatation, glycogenolysis, lipolysis, and 
bronchodilation.56 In the heart failure context, most patients are routinely treated with 
beta-adrenergic blockade, which makes the study of the stress response challenging 
because SAM stress responses are inhibited by beta blockers.57,58 Much of the literature 
on animals and humans suggests that psychological factors can influence the HPA axis, 
which controls the release of cortisol, an important glucocorticoid that is secreted by the 
adrenal cortex. Over the past decades, many investigators have concluded that physical 
and psychological stressors are capable of activating the HPA axis and increasing cortisol 
level in the blood stream.59 However, the effects of psychological stressors on this 
physiological system are variable.60  This variability is likely a result of differences in an 
individual’s cognitive appraisal of a stressor.  
The thalamus and frontal lobes of the brain put together the sensory information 
and assess the significance or meaning of environmental stimuli in a process called 
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cognitive appraisal. Based on this appraisal, an emotional response will be generated 
through connections from the prefrontal cortex to the limbic system. The limbic system, 
which is connected to the hypothalamus, serves as the primary conduit for HPA 
activation. The activation begins when the hypothalamus exudes the corticotropin 
releasing hormone (CRH) which stimulates the anterior pituitary to secrete 
adrenocorticotropin hormone (ACTH), which in turn stimulates the adrenal cortex to 
secrete cortisol in the blood.61,62  
Through cortisol, the HPA supports physiological functions and regulates other 
systems. Cortisol plays a major role in metabolism through the glycogenolysis process 
that converts amino acids and fats to glucose in the liver to meet body requirements. In 
addition, cortisol inhibits the immune system and regulates the inflammation process.59 
Furthermore, the sympathetic nervous system requires a certain level of cortisol to 
perform physiologic functions effectively, such as inducing vasoconstriction or 
increasing heart rate.59 However, prolonged cortisol activation due to frequent exposure 
to stressors is associated with many negative biological effects such as suppression of 
aspects of the immune system, damage to hippocampal neurons, and development and 
progression of certain chronic diseases like diabetes and hypertension.52,63 In heart 
failure, cortisol may contribute to the progression of cardiac damage by acting as a 
mineralocorticoid receptor (MR) agonist in cardiac muscle, which causes cortisol to 
mimic the physiological and pathophysiological effects of aldosterone.64-67  
In a study conducted by Guder et al., higher levels of serum cortisol and 
aldosterone were independent predictors of mortality in HF patients.67 Thus, determining 
whether the stressors that are associated with HF activate the cortisol system and 
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contribute to the onset or exacerbation of certain health outcomes is crucial. Based on this 
literature, measurement of cortisol is an appropriate reflection of response to stressors in 
patients with HF.  
In the third chapter of this dissertation we aimed to examine the association of 
stress with cardiac event-free survival; examine the relationship of stress with salivary 
cortisol; and examine the association of salivary cortisol level with cardiac event-free 
survival. This study was a longitudinal study with a sample of 81 HF patients. We 
hypothesized that stress and salivary cortisol are predictors of event-free survival in HF 
patients. In addition, we hypothesized that stress is a predictor of salivary cortisol level in 
HF patients. Cox regression analyses and multiple linear regression were used for data 
analysis. Stress was not a significant predictor of event free survival in HF. Salivary 
cortisol was a significant predictor of event free survival in the unadjusted model but not 
in the adjusted model. Stress was not a significant predictor of salivary cortisol level. But 
do these results suggest that stress is not a predictor of health outcomes in HF patients or 
is there an indirect association of stress with outcomes that is mediated through another 
construct that remains unexplored. 
Cognitive appraisal is the patient’s perception of a stressor with an assessment to 
the stress level that caused by it. It also includes an assessment of the patient’s goals and 
resources available to face that stressor.68,69 Psychologists have long realized that people 
have considerable differences in their appraisals of and response to stressors. Thus, 
cognitive appraisal became a core theory in many stress models.59,68 Cognitive appraisal 
has the following forms: (1) irrelevant when the situation has no effect on the patient, (2) 
benign positive when the situation is appraised as positive, (3) or stressful.68  When the 
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event is viewed as stressful, then it can be appraised in three categories: (1) Harm / loss, 
which refers to a harmful occurrence like illness or damage to self or social esteem; (2) 
Threat, which refers to suspected harm that does not occur; and (3) Challenge, in the 
opportunity occurs for gain and growth. 68 In a study conducted by Harvey et al.,70 
cognitive appraisal played an important role in stress responses, which have been proven 
to impair health performance. Harm/loss and threat cognitive appraisals were associated 
with impaired performance, lower quality of life, and poor health outcomes when 
compared to challenge cognitive appraisal.71,72  
The cognitive appraisal mechanism can give a general view or prediction about 
patients’ psychological and physical coping. 73 The stress appraisal and coping model, 
developed by Lazarus and Folkman,68 was a starting point for recent research in which 
stress and coping were investigated. Lazarus and Folkman68 define coping as “Constantly 
changing cognitive and behavioral efforts to manage specific external and/or internal 
demands that are appraised as taxing or exceeding the resources of the person.” Coping 
can be also defined as cognitive or behavioral attempts to manage, master, or alter the 
stressor by reducing it or by tolerating it.74,75 Two major types of coping have been 
addressed. 68 The first is emotion-focused coping, which describes the patient attempts to 
control his or her emotional response without changing the stressor because the patient 
believes no change can be made on the stressor. 68,76  Emotion-focused coping can be 
divided into two categories (active emotional coping and avoidant emotional coping) 
based on the strategies that are used by the patient to reduce or manage the emotional 
distress relating to the stressor.77,78  Active emotional coping includes venting, positive 
reframing, humor, acceptance, and emotional support strategies. Avoidant emotional 
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coping includes self-distraction, denial, behavioral disengagement, self-blame, and 
substance use.79,80 The second major type of coping is problem-focused coping, which 
occurs when the individual responds to attempt to control, alter, and manage the stressor. 
68,76 Problem-focused coping contains cognitive and behavioral strategies such as 
planning, positive reinterpretation and growth, reaching out for instrumental support, and 
religion.79,80 
The predominant view of emotion-focused coping in the stress and coping 
literature is that it is a maladaptive form of coping associated with poor health 
outcomes.81,82 In contrast, problem-focused coping that aims to alter or manage the 
stressor is positively associated with better adjustment and outcomes in the literature.82 
According to Folkman,75 emotion-focused coping strategies are used in situations with 
high levels of uncertainty, where patient identifies few opportunities for effective 
beneficial change. In contrast, problem-focused coping strategies are used in situations 
where patient feels a sense of personal efficacy and perceives the possibility for making 
positive change.75 Patients with HF who used problem focused coping experienced 
positive health-related quality of life and lower levels of depression. 83-85 In contrast, 
patient who used emotion focused experienced a negative effect on health-related quality 
of life and higher levels of depression.83-85 Practically, avoidant emotional coping is 
significantly associated with higher levels of anxiety, poorer health outcomes, and lower 
health-related quality of life. 86’87  Avoidant emotional coping is associated with lower 
health-related quality of life in patient with head and neck cancer disease.87  
In a study conducted by Ransom et al.88, cancer patients, who focused on their 
illnesses by concentrating  their efforts on managing symptoms and seeking out 
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information about their illness, experienced more positive changes in their physical health 
and quality of life. 88 Another  study conducted on job stress, employees who used 
problem-focused coping experienced better performance as compared with other 
employees who used emotion- focused coping.58 Furthermore, when a challenge (versus a 
threat) is perceived, problem-focused coping ensued, which leads to better health 
outcomes. In contrast, threat, harm and loss cognitive appraisals are significantly 
correlated with emotional-focused coping, which leads to unsatisfactory health 
outcomes.71,89-93  
Due to the need to understand these concepts in HF population, a descriptive 
longitudinal study with a sample of 88 HF patients was conducted and presented in 
Chapter Four of this dissertation. The purpose of Chapter Four was to describe self-
reported stress level, cognitive appraisal and coping among patients with HF, and to 
examine the association of cognitive appraisal and coping strategies with event-free 
survival. A model based on the literature to date 10-15,44,45,70-72,77-80,94, 81,82 (see Figure 1) 
was proposed and presented in Chapter Four in a trial to understand the relationships 
between the different variables through testing the proposed model. Two tailed Pearson 
correlation was used to determine relationships among the variables. Cox regression 
analyses were used to determine if coping style or cognitive appraisal type predicted 
event-free survival. Linear and multiple regressions were used to determine the 
association of stress with coping style and cognitive appraisal type, and the association of 
cognitive appraisal type with coping style.  Results showed that stress level was 
significantly associated with harm and loss cognitive appraisal. Harm and loss cognitive 
appraisal was significantly associated with avoidant emotional coping. Threat cognitive 
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appraisal was also significantly associated with avoidant emotional coping. Linear and 
Cox regression showed that harm loss cognitive appraisal was a significant predictor of 
avoidant emotional coping and event free survival. Finally avoidant emotional coping 
was a significant predictor of event free survival among HF patients in the unadjusted 
model. All other relations in the model were not significant. 
In Chapter Five, an integrated summary and conclusions from the findings of the 
previous four chapters is presented. Recommendations for clinical practice and future 
research are included in this chapter. The findings from each chapter in this dissertation 
fill a gap in knowledge about HF patient health outcomes related to psychosocial factors 
that may contribute to poor outcomes. The dissertation also recommend future research 
studies and suggested interventions to limit the effect of the negative psychosocial factors 
on the health outcomes in HF population.  
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CHAPTER TWO 
The Association of Co-morbid Symptoms of Depression and Anxiety with All-
Cause Mortality and Cardiac Rehospitalization in Patients with Heart failure 
Introduction  
In the United States, heart failure (HF) is a major public health problem that 
affects around 5.7 million patients, with 670,000 newly diagnosed patients each year 
2.The total costs of HF in the United States are estimated to be $37billion each year2. 
Although there have been  significant therapeutic advances in pharmacological and 
surgical treatment of HF, the one-year mortality rate of HF patients with progressive 
symptoms still approaches 40%, which is the same for some types of aggressive cancer 
7,8.  Even patients who have less serious HF symptoms usually experience impaired 
quality of life 8. The high mortality and morbidity rates associated with HF are still not 
well explained 9. Patients with HF simultaneously experience multiple psychological 
symptoms that affect health outcomes such as symptoms of depression and anxiety.  
Depression is a mood disorder that interferes with an individual’s ability to 
perform daily life activities 16,17. Depression is characterized by specific symptoms such 
as changes in appetite, sleep disturbance, fatigue, agitation, feelings of guilt or 
worthlessness, and concentration problems 11,18,19. Depression is a significant clinical 
problem that is found in a substantial number of patients with HF; around 20% of 
outpatients who have HF have major depressive symptoms, and up to 48% of outpatients 
experience clinically significant depressive symptoms. 20 Furthermore, HF patients who 
are depressed are two times more likely to be hospitalized and face death than those who 
are not depressed 21. Depression is associated with unhealthy behaviors like smoking and 
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unsatisfactory patient compliance. 22,23 Moreover, depression is associated with 
pathophysiological mechanisms that negatively affect cardiac conditions, such as 
hypercortisolemia, impaired platelet function, and reduced heart rate variability. 24-27  
Anxiety is a negative emotional state resulting from the perception of threat, and 
is described as the result of a perceived inability to predict, control, or gain from the 
threatening situation. 11,16 Anxiety is significantly associated with a higher occurrence of 
adverse cardiac events and cardiac death in the general population and in patients with 
coronary artery disease. 10,16 Anxiety also has been linked to pathophysiological 
mechanisms that could mediate negative outcomes such as reduced heart rate variability 
and baroreflex cardiac control, cardiac arrhythmias, and sudden death. 28-30 Patients with 
HF have a 60% higher level of anxiety compared to healthy elders; 40% percent of 
patients suffer from major anxiety. 11,31,32 In addition, patients with HF tend to have 
higher levels of anxiety compared to other cardiac disease patients or even cancer and 
lung patients. There are, however, contradictory results about the association between 
anxiety and health outcomes in patients with HF.33,34  
Individually, depression and anxiety are associated with survival in HF patients; 
however, the association of co-morbid symptoms of anxiety and depression with 
morbidity and mortality in patient with HF is unknown. Thus, the purpose of this study 
was to examine whether co-morbid symptoms of depression and anxiety are associated 
with all-cause mortality or rehospitalization for cardiac causes in patients with HF. 
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Method 
Design, sample, and setting 
Data from this study were from the Heart Failure Health-Related Quality of Life 
Collaborative Registry 95, housed at the University of Kentucky College of Nursing. This 
is a longitudinal database that includes data from patients from across the United States 
and from several international sites (n = 4076).  From this database, we analyzed data 
from all patients who had data on anxiety, depression, and mortality and rehospitalization 
outcomes (n = 1,260).  The demographics (i.e., age, gender, and ethnicity) and New York 
Heart Association (NYHA) class of the sample used in the current study were compared 
statistically to those in the registry who did not have data on anxiety, depression and 
outcomes. There were no differences between these two groups on these four variables. 
The database was accessed through the Research and Interventions for Cardiovascular 
Health (RICH) program at the University of Kentucky. Inclusion criteria for the original 
database were patients with a confirmed diagnosis of HF with impaired or preserved left 
ventricular systolic function. Patients were excluded if they had valvular heart disease, 
were referred for heart transplantation, had a history of cerebrovascular accident or 
myocardial infarction in the past 6 months, and had a co-existing terminal illness. Data on 
mortality and rehospitalization were collected over 12 months. 96,97 
Measures 
Symptoms of Depression and Anxiety 
Depressive symptoms. The Patient Health Questionnaire (PHQ-9)98,99 was used to 
measure depressive symptoms in this study. The PHQ-9 is a 9-item, self-reported 
measure of depression that reflects the severity of depressive symptoms over the past two 
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weeks. 100,101 Patients respond to each item by using a Likert scale in which responses 
range from 0 (not at all) to 3 (nearly every day). The total summary score can range from 
0 to 27; a higher score reflects more severe depressive symptoms. Good internal 
consistency, stability, construct and concurrent validity of the PHQ-9 have been 
supported. 97,101 The standard published cut point of 10 was selected in this study for 
PHQ-9 to identify those in the sample who were depressed and those who were not 
depressed. 97 This cut point was reported to have 88% sensitivity and 88% specificity for 
diagnosing major depression.100,101 
Anxiety. The Brief Symptom Inventory (BSI) anxiety subscale was used to 
measure current symptoms of anxiety. 102,103 The subscale consists of 6 questions, each of 
which are scored by patients using a scale that ranges from 0 (not at all) to 4 (extremely).  
The total score is calculated by summing all 6 item scores and taking the mean. Thus, the 
possible range of scores for the anxiety scale is 0 to 4 with higher scores indicative of 
higher levels of anxiety. The BSI has demonstrated internal consistency, stability, 
construct and concurrent validity in other studies. 102,103  In this study, the Cronbach’s 
alpha of the anxiety scale was 0.82.A standard published mean of 0.35 was used in this 
study for BSI to identify those in the sample who were anxious and those who were not 
anxious. 104  
Mortality and Rehospitalization Outcomes 
All-cause mortality, or rehospitalization for cardiac causes were the outcome 
variables in this study. By monthly phone call follow up and by reviewing electronic and 
non-electronic hospital medical records, all dates of and reasons for hospitalization and 
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death were collected. Furthermore, death certificates were acquired to confirm the cause 
of death. Patients were followed for at least 12 months. 
Demographic and clinical variables   
Data on demographic variables and clinical characteristics were collected by 
reviewing medical records and interviewing patients. These variables included age, 
gender, ethnicity, and New York Heart Association (NYHA) class. The NYHA class 
indicates the level of functional impairment reported by patients as a result of symptoms 
and was rated by trained research nurses. These variables were selected because of their 
effects on the outcome variable as suggested in the literature. 97,100  
Statistical Analysis 
Data were analyzed using SPSS software, version 20.0 (SPSS Inc., Chicago, IL). 
Descriptive statistics, including mean, standard deviation and frequency distribution, 
were used to describe sample characteristics. In the main analysis, anxiety and depression 
were treated first as continuous level variables, then as categorical variables. In order to 
create the categories, variables were created for each individual describing the presence 
of depression and anxiety using published, standard cut points (10 and 0.35, 
respectively). Patients were then divided into the following four groups: 1) patients who 
had neither depression nor anxiety; 2) patients who had depression; 3) patients who had 
anxiety; and 4) patients who had comorbid anxiety and depression. Sample socio-
demographic and clinical characteristics (i.e., age, gender, ethnicity, NYHA class, 
anxiety level and depression level) between the four groups were compared using Х2or 
ANOVA as appropriate to the level of measurement. Hierarchal Cox regression analyses 
were used to determine whether co-morbid symptoms of depression and anxiety, 
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independently, predicted mortality alone, or cardiac rehospitalization alone. Data were 
forced into the regression in order to provide simultaneous control. The following 
covariates were considered: age, gender, ethnicity, NYHA class, and anxiety and 
depression. We first tested the interaction term defining the continuous level variables for 
anxiety and depression, and the outcomes. We next tested the grouping variables 
identifying co-morbid depression and anxiety status. The assumptions of hierarchal Cox 
regression were tested and no violation occurred. A p-value of 0.05 was considered 
statistically significant. 
Results 
Demographic and clinical characteristics of patients (N = 1,260) are summarized 
in Table 2.1. The mean levels of anxiety and depression were 0.82 with a SD of 0.92, 
7.48 with a SD of 6.22, respectively. Using the clinically defined cut points, 52.9 % of 
the participants were anxious and 32.5% were depressed. When the sample was divided 
into the four predefined groups, a total of 5.7% of the patients had depressive symptoms 
only, 26.1% had anxiety symptoms only, and 26.8% had co-morbid symptoms of anxiety 
and depression.  Eighty-two (6.5%) of the participants died and 182 (14.4%) were 
hospitalized during the study. 
Hierarchal Cox regression was run with anxiety and depression treated as 
continuous level variables and all-cause mortality as the outcome. In the first block in 
which demographic variables were entered, only older age was a significant predictor of 
all-cause mortality. In the second block, NYHA class was entered to the model. Age 
remained a significant predictor. Additionally, worse NYHA functional class was a 
significant predictor in this block. In the final block, age (HR 1.03; 95% CI: 1.01-1.05; p 
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= 0.009), worse NYHA class (HR 3.90; 95% CI: 2.39-6.36; p < 0.001), and higher levels 
of depression (HR 1.06; 95% CI: 1.01-1.11; p = 0.012) were significant predictors of all-
cause mortality among HF patients. The interaction between anxiety and depression (HR 
1.02; 95% CI: 1.01-1.03; p = 0.002) was also a significant predictor of all-cause 
mortality. However, anxiety (HR 1.07; 95% CI: 0.79-1.45; p = 0.652) was not a 
significant predictor of all-cause mortality (Table 2.2).  
Another hierarchal Cox regression was run with anxiety and depression treated as 
continuous level variables and cardiac rehospitalization as the outcome. In the first block 
in which demographic variables were entered, older age, female gender, and ethnicity 
(African Americans compared to Caucasians, and Caucasians compared to other 
ethnicities) were significant predictors of cardiac rehospitalization. In the second block, 
NYHA class was entered to the model. All previous variables remained significant 
predictors. Additionally, worse NYHA functional class was a significant predictor in this 
block. In the final block, anxiety, depression, and the interaction between anxiety and 
depression were entered to the model. Age (HR 0.99; 95% CI: 0.97-1.00; p = 0.016), 
female gender (HR 1.40; 95% CI: 1.01-1.94; p = 0.042), African Americans ethnicity 
compared to Caucasians ethnicity (HR 2.43; 95% CI: 1.67-3.54; p < 0.001), and 
Caucasians ethnicity compared to other ethnicities (HR 0.30; 95% CI: 0.10 - 0.95; p = 
0.040), and worse NYHA functional class (HR 2.62; 95% CI: 1.94-3.55; p < 0.001) were 
significant predictors of cardiac rehospitalization among HF patients. However, anxiety 
(HR 0.93; 95% CI: 0.75-1.15; p = 0.505), depression (HR 1.02; 95% CI: 0.99-1.05; p = 
0.290), and the interaction between anxiety and depression (HR 1.00; 95% CI: 1.00-1.01; 
p = 0.648) were not significant predictor of cardiac rehospitalization (Table 2.3). 
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In the next analysis, anxiety and depression were treated as categorical variables 
and the four categories previously defined were entered in a hierarchical cox regression 
to predict all-cause mortality (Table 2.4). In the first block in which demographic 
variables were entered, only older age was a significant predictor of all-cause mortality. 
In the second block, NYHA class was entered to the model. Age remained a significant 
predictor. Additionally, worse NYHA functional class was a significant predictor in this 
block. In the final block, the four anxiety and depression groups were entered into the 
model. The final model demonstrated that that older age, worse NYHA class, and 
comorbid anxiety and depression were the significant predictors of all-cause mortality.  
In this analysis neither anxiety alone nor depression alone were significant predictors of 
all-cause mortality among HF patients (Figure 2.1). Based on these results, HF patients 
with comorbid anxiety and depression are 2.6 times more likely to die compared to those 
who are neither depressed nor anxious (Table 2.4 and Figure 2.1). 
A final hierarchical Cox regression was used where anxiety and depression were 
treated as categorical variables to predict cardiac rehospitalization (Table 2.5). In the first 
block in which demographic variables were entered, older age, female gender, African 
American ethnicity compared to Caucasian, and Caucasian ethnicity compared to other 
ethnicities were significant predictors of cardiac rehospitalization. In the second block, 
NYHA class was entered to the model. Age, gender, and ethnicity remained significant 
predictors. Additionally, worse NYHA functional class was a significant predictor in this 
block. In the final block, the four anxiety and depression groups were entered into the 
model. The final model demonstrated that that older age, female gender, African 
American ethnicity compared to Caucasian, Caucasian ethnicity compared to other 
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ethnicities, and worse NYHA class were the significant predictors of cardiac 
rehospitalization.  In this analysis neither anxiety alone, depression alone, or comorbid 
anxiety and depression were significant predictors of cardiac rehospitalization among HF 
patients (Table 2.5 and Figure 2.2). 
Discussion 
     Several important findings are evident from this study. First, anxiety and 
depressive symptoms are common and are commonly comorbid in patients with HF. The 
majority of our sample experienced symptoms of depression or anxiety, or both. Second, 
we demonstrated that comorbid anxiety and depressive symptoms, when considered as a 
clinically relevant categorical variable, was predictive of all-cause mortality, while 
anxiety and depressive symptoms considered alone were not independent predictors of 
the same outcome. When treated as continuous level variables, both comorbid depression 
and anxiety, and depression alone were significant predictors of all-cause mortality. None 
of the psychological variables were predictive of the cardiac rehospitalization outcome, 
regardless of whether entered as continuous or categorical level variables. The findings of 
this study emphasize the hazardous effects of comorbid anxiety and depressive symptoms 
on the mortality rate of adults with HF. 
More than 50% of HF patients suffer from significant symptoms of anxiety or 
depression. 11,31,32 HF patients’ mortality rate is around 40% within the first year of 
diagnosis despite current medical and surgical advances. 7,8 Because anxiety and 
depression have been consistently associated with poorer health outcomes,33,34 we wanted 
to examine whether they also explained the high rates of mortality among HF patients. 
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This study is one of few to investigate comorbid anxiety and depression and its 
effect on all-cause mortality and cardiac rehospitalization in patients with HF. Frasure-
Smith and colleagues found that anxiety and depression were associated with cardiac 
mortality using a single instrument (the General Health Questionnaire-20) to assess 
psychological distress. However, these researchers did not control for disease severity, 
age, and other risk factors. In addition, the additive effect of anxiety and depression was 
not studied. 105 In another study by Doering and colleagues, 106 researchers focused on 
mortality and demonstrated that co-morbid anxiety and depression were predictive of all-
cause mortality in patients with coronary artery disease, but did not study 
hospitalizations. Doering et al. also used the Multiple Adjective Affect Checklist 
(MAACL-D) to measure depression. 106 However, in the HF population, the PHQ-9 is 
considered one of the best instruments to measure depression. 100,101 In addition, Doering 
et al treated depression and anxiety as a categorical variables without consideration of 
these variables treated at the continuous level, which may mask expression of the 
phenomenon. 
Our study is unique in its focus on comorbid anxiety and depression and its effect 
on cardiac rehospitalization and mortality for all causes in HF patients. Our strengths 
included the use of valid and reliable instruments to measure depression and anxiety 
symptoms in patients with HF, and a large sample size. Furthermore, we treated anxiety, 
depression, and both as continuous-level and categorical-level variables, and we 
controlled for multiple covariates such as age, gender, ethnicity, and NYHA class.  
Our study showed that depression alone, and the interaction of depression and 
anxiety are the only significant psychological predictors of all-cause mortality among HF 
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patients when we included continuous measures of anxiety, depression, and the 
interaction between anxiety and depression in our model. When we conducted the 
analysis using categorical variables, we found that comorbid anxiety and depression was 
the only significant psychological predictor; neither anxiety nor depression alone was a 
significant predictor. For depression alone, the lack of significance may be explained by 
the low number of individuals who had depression alone (n=72). However, when we run 
the analysis again using an unadjusted model, depression alone (HR 2.53; 95% CI: 1.04-
6.16; p = 0.042) was a significant predictor of all-cause mortality among HF patients. 
This finding suggests that sample size alone does not explain the failure of depression to 
independently predict the outcome, but rather, suggests that depression, in the company 
of other psychological, demographic and clinical predictors of outcomes, depression 
alone is not an independent predictor.  
Our results that psychological factors are important mechanisms for the high 
mortality rate in HF. Anxiety and depression are strongly associated with unhealthy 
practices such as smoking, drinking, and unsatisfactory patient compliance 22,23. They are 
also associated with physiological changes that can lead to hospitalization and death such 
as hypercortisolemia, impaired platelet function, reduced heart rate variability, cardiac 
arrhythmias, and sudden death 24-27,28-30. Thus, these behavioral and physiological factors 
associated with anxiety and depression likely contribute to the continuing high morbidity 
and mortality in HF. 
Study limitations 
A potential limitation of our study was the use of self-reported measurement of 
symptoms of anxiety and depression, rather than diagnostic interviews. However, a strict 
24 
 
protocol was used to measure anxiety and depression, and we and others have previously 
demonstrated the reliability and validity of the self-report instruments used in patients 
with HF. 107-110 Another possible limitation was the absence of treatment, and failure to 
adjust for some covariate such as smoking and alcohol consumption that may contribute 
to the phenomena. However, the major covariates, age, gender, ethnicity, and NYHA 
class, were controlled for in this study. This, along with the large sample size, are 
strengths of the study.  
Conclusion 
    Our findings have clinical and research implications. Comorbid anxiety and 
depression symptoms are a better predictor of death in HF patients than anxiety or 
depression alone. Thus, to improve outcomes in patients with HF, attention must be paid 
by healthcare providers to the assessment and management of co-morbid symptoms of 
depression and anxiety. Future studies should investigate and evaluate strategies or 
methods that able to screen and treat depression and anxiety symptoms in HF patients 
effectively. 
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Table 2.1: Sample baseline characteristics (N = 1260) 
Characteristic N (%) OR MEAN ± SD 
Age 63.57 ± 13 
Anxiety score 0.82 ± 0.92 
Depressive symptoms score 7.48 ± 6.22 
Gender 
  Male 
  Female  
 
804 (63.8) 
456 (36.2) 
Ethnicity 
  Caucasian 
  African American 
  Other 
 
1017 (80.7) 
153 (12.1) 
90 (7.1) 
New York Heart Association class 
  I/II 
  III/IV 
 
664 (52.7) 
596 (47.3) 
Anxiety and depression categories 
  No Anxiety or Depression           
  Depression Only  
  Anxiety Only  
  Co-morbid Anxiety and Depression   
 
521 (41.3) 
72 (5.7) 
329 (26.1) 
338 (26.8) 
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Table 2.2: Cox proportional hazard regression of variables associated with all-cause 
mortality in patients with HF, and anxiety and depression treated as continuous level 
variables.  
Predictor Variables Exp.(B) 95% CI       P  
 
 Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than 
       African American 
NYHA class  III/IV compared to I/II  
 
   1.03 
   1.06 
   0.30 
   0.55 
 
  3.90                       
 
1.01 – 1.05 
0.67 – 1.68                     
0.07 – 1.23 
0.17 – 1.76 
 
2.39 – 6.36 
 
0.009 
0.805 
0.095 
0.315 
 
< 0.001 
Anxiety 
Depression 
Anxiety*Depression 
    1.07 
    1.06 
    1.02 
0.79 – 1.45 
1.01-1.11 
1.01– 1.03 
0.652 
0.012 
0.002 
 Overall Model (χ2 = 60.08, df. = 6; p <0.001); NYHA = New York Heart Association  
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Table 2.3: Cox proportional hazard regression of variables associated with cardiac 
rehospitalization in patients with HF, and anxiety and depression treated as continuous 
level variables.  
Predictor Variables Exp.(B) 95% CI       P  
 
 Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than 
       African American 
NYHA class  III/IV compared to I/II  
 
   0.99 
   1.40 
   2.43 
   0.30 
 
  2.62                       
 
0.97 – 1.00 
1.01 – 1.94                     
1.67 – 3.54 
0.10 – 0.95 
 
1.94 – 3.55 
 
0.016 
0.042 
< 0.001 
0.040 
 
< 0.001 
Anxiety 
Depression 
Anxiety*Depression 
    0.93 
    1.02 
    1.00 
0.75 – 1.15 
0.99-1.05 
1.00– 1.01 
0.505 
0.290 
0.648 
 Overall Model (χ2 = 87.37, df. = 6; p <0.001) 
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Table 2.4: Cox proportional hazard regression of variables associated with all-cause 
mortality in patients with HF, and anxiety and depression treated as categorical variables.  
Predictor Variables Exp.(B) 95% CI       P  
Block I 
Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than   
African American 
 
 
   1.02 
   0.94 
   0.30 
   0.59 
  
1.00-1.04                     0.021 
0.60-1.50                     0.806 
0.07-1.23                     0.094 
0.19-1.88                     0.374 
Block II 
Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than 
African American 
NYHA class  III/IV compared to I/II 
 
   1.02 
   0.98 
   0.28 
   0.56 
 
  4.19 
  
1.00-1.04                     0.048 
0.62-1.55                     0.929 
0.07-1.17                     0.081 
0.18-1.77                    0.323 
 
2.58-6.81                   <0.001 
Block III (Final Model) 
   Age  
  Female Gender  
  African American compared to Caucasian  
 Caucasian compared to ethnicity other than 
African American 
  NYHA class  III/IV compared to I/II 
 
1.03 
0.92 
0.30 
0.56 
 
3.62                  
 
1.01 – 1.05 
0.58 – 1.45 
0.07 – 1.23 
0.18 – 1.80 
 
2.14 – 3.61 
 
0.006 
0.717 
0.094 
0.335 
 
<0.001 
29 
 
 
  
 
Depression Only 
Anxiety Only 
Comorbid Anxiety and Depression 
1.67 
1.35 
2.59 
 
0.68 – 4.12 
0.74 – 2.46 
1.49 – 4.49 
 
0.263 
0.332 
0.001 
 
Overall Model (χ2 = 62.78, df. = 8; p <0.001);  NYHA = New York Heart Association 
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Table 2.5: Cox proportional hazard regression of variables associated with cardiac 
rehospitalization in patients with HF, and anxiety and depression treated as categorical 
variables.  
Predictor Variables Exp.(B) 95% CI       P  
Block I 
Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than   
African American 
 
 
   0.99 
   0.71 
   2.49 
   0.31 
  
0.98-1.00                     0.036 
0.52-0.99                     0.040 
1.71-3.61                     <0.001 
0.10-0.97                     0.044 
Block II 
Age  
 Female Gender  
 African American compared to Caucasian  
Caucasian compared to ethnicity other than 
African American 
NYHA class  III/IV compared to I/II 
 
   0.99 
   0.71 
   2.44 
   0.30 
 
  2.60 
  
0.97-1.00                     0.018 
0.52-0.99                     0.040 
1.69-3.56                     <0.001 
0.10-0.94                    0.040 
 
1.60-3.50                   <0.001 
Block III (Final Model) 
   Age  
  Female Gender  
  African American compared to Caucasian  
 
0.99 
0.70 
2.47 
0.30 
 
0.97 – 0.99 
0.51 – 1.97 
1.70 – 3.61 
0.10 – 0.95 
 
0.035 
0.034 
<0.001
0.040 
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 Caucasian compared to ethnicity other than 
African American 
  NYHA class  III/IV compared to I/II 
 
2.52                  
 
1.85 – 3.43 
 
 
<0.001 
Depression Only 
Anxiety Only 
Comorbid Anxiety and Depression 
1.07 
1.01 
1.18 
 
0.55 – 2.09 
0.70 – 1.47 
0.81 – 1.71 
 
0.847 
0.953 
0.391 
 
Overall Model (χ2 = 88.59, df. = 8; p <0.001);  NYHA = New York Heart Association 
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CHAPTER THREE 
Examination of the Potential Association of Stress with Morbidity and Mortality 
Outcomes in Patient with Heart Failure 
Introduction 
Worldwide, heart failure (HF) is considered a major public health problem.2,111-118 
Although there have been significant therapeutic advances in pharmacological and 
surgical treatment of HF, hospital admission and readmission rates are extremely high for 
exacerbations of HF, and the one-year mortality rate of HF patients with progressive 
symptoms still approaches 40%.7,8,119,120 The high mortality and morbidity rates 
associated with HF are not completely explained by biological mechanisms, 9 as 
psychological factors are important predictors of morbidity and mortality in HF. One 
psychological factor that might contribute to morbidity and mortality in patients with HF 
is stress. 9,11,121-125  
Stress is the condition that occurs when environmental demands exceed an 
individual’s ability to adapt to the demands. 43 A prerequisite for stress to occur is the 
individual’s perception that stressors are perceived as a persistent threat to their physical 
and/or psychological health or well-being.42 Stress is an umbrella term that summarizes 
the effects of psychological and environmental stressors on an individual’s physical and 
mental health.44,45 Heart failure is commonly perceived by patients as a very stressful 
experience both physically and psychologically.11,12  
There is limited information about the relationship between stress and HF. 
However, in patients with cardiovascular disease, psychological stress was associated 
with multiple adverse effects on patient health outcomes.46-48,126,127 In patients with 
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cardiovascular disease, psychological stress has been associated with decreased coronary 
artery blood supply, greater severity of cardiac disease, worse prognosis, and poorer 
cardiac function.49-53 Stress is also associated with multiple psychological factors such as 
anxiety and depression that have negative effects on health outcomes like mortality and 
morbidity in HF and cardiac disease.121,128-130  
Given the likelihood that HF is a substantial stressor for many patients, the 
examination of the role of stress on health outcomes in patients with HF is important. The 
specific aims of this study were to (1) examine the association of stress with 6-month 
cardiac event-free survival, controlling for anxiety, depression, and New York Heart 
Association (NYHA) functional class; (2) examine the relationship of stress with salivary 
cortisol; and (3) examine the association of salivary cortisol level with 6-month cardiac 
event-free survival, controlling for age, gender, and NYHA class. We hypothesized that 
stress and salivary cortisol are predictors of event-free survival in HF patients. In 
addition, we hypothesized that stress is a predictor of salivary cortisol level in HF 
patients. 
Method 
Design, sample, and setting 
A prospective design was used in which patients were followed for 6 months to 
determine occurrence of 6-month cardiac event-free survival, defined as time to the 
combined endpoint of cardiac rehospitalization or all-cause death. This study was a part 
of the Heart Outcomes Prevention Evaluation (HOPE) study at the University of 
Kentucky that investigated depression among hospitalized patients with HF. The parent 
study and the current study were approved by the Institutional Review Board at the 
36 
 
University of Kentucky. The sample consisted of 81 patients with confirmed HF who 
were hospitalized for cardiac reasons (i.e., hospitalization for HF, acute coronary 
syndrome, dysrhythmias) at the University of Kentucky Chandler Medical Center or 
Good Samaritan Hospital which are located in Lexington, Kentucky.  
Patients with a diagnosis of chronic HF confirmed by echocardiogram and 
cardiologist were eligible for participation in the study if they met the following criteria: 
a) admitted to the hospital with a primary or secondary diagnosis of exacerbation of 
chronic HF or any other cardiac diagnosis, b) 21 years or older, c) able to read and speak 
English, and d) no obvious cognitive impairment. Patients with HF with either preserved 
or non-preserved ejection fraction were included. Patients were excluded from the study 
for the following reasons: a) co-existing terminal illness likely to be fatal within the next 
6 months, b) presence of a left ventricular assist device, continuous inotropic infusion, or 
hospice care, c) active suicidality (defined as choosing option 2 or 3 on item 9 of the 
Beck Depression Inventory-II), d) history of the death of a spouse or child within the past 
month, e) history of psychotic illness or bipolar illness, f) current alcohol dependence or 
other substance abuse, and g) new-onset HF. 
Measures 
Stress 
 
Stress was measured using the brief version of the Perceived Stress Scale.131 The 
brief version consists of a four-item scale which has been demonstrated to be reliable and 
valid.131 The four items are:  (1) how often have you felt that you were unable to control 
the important things in your life?, (2) how often have you felt confident about your ability 
to handle your personal problems?, (3) how often have you felt that things were going 
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your way?, and (4) how often have you felt difficulties were piling up so high that you 
could not overcome them? Each item is rated by respondents on a scale ranging from 0 
(never) to 5 (very often). Higher scores indicate greater levels of stress. In this study, the 
Cronbach’s alpha of the 4-items perceived stress scale was 0.70. 
Event Free Survival 
 
Event-free survival was defined as the combined endpoint of cardiac 
rehospitalization or all-cause death. Hospitalization data were determined through a 
combination of patient and family interviews and a review of medical records. 
Hospitalizations were verified by trained research assistants who reviewed medical 
records and clinic notes on a weekly basis. Given the possibility that patients could have 
been hospitalized at different facilities other than the three sites involved in the study, 
trained research assistants carefully questioned the patients or family members by phone 
to determine if hospitalization had occurred. 
All-cause mortality was determined by interview with the patient’s family, 
medical record review and review of county death records. At enrollment, the patient was 
asked for contact information for a close friend or family member in case the patient 
could not be contacted. At follow-up if a patient could not be reached by phone, hospital 
records were searched. When information regarding the patient was not available, family 
members or friends were contacted. If these contacts could not be reached, county death 
records were used to determine patient death. 
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Salivary Cortisol 
 
 
Cortisol was measured from saliva obtained from patients at baseline through an 
unstimulated whole expectorated saliva collection protocol. Patients were provided a 20 
mL vial containing freeze dried protease inhibitor. Patients were asked to swallow once 
and begin expectorating approximately every 20 to 30 seconds until 5 ml is collected. 
The specimen was kept on ice until returned to the lab. Salivary sample was obtained in 
the morning (9am) on the day of enrollment. The salivary samples were stored in a -80°C 
freezer until they were analyzed using a commercially available enzyme immunoassay kit 
designed for cortisol quantification in saliva (Salimetrics LLC, State College, PA, USA). 
This assay has a sensitivity of <0.007 ug/dL and is strongly correlated with serum cortisol 
measurement (0.91). Salivary cortisol is considered a more accurate and reliable measure 
for the clinical assessment of adrenocortical function than serum cortisol.132,133 
Depressive Symptoms 
The Patient Health Questionnaire-9 (PHQ-9)98,99  was used to measure depressive 
symptoms. The PHQ-9 is a 9-item, self-reported measure of depressive symptom 
severity. Patients respond to each item on a Likert scale ranging from 0 (not at all) to 3 
(nearly every day). The total summary score can range from 0 to 27; a higher score 
reflects more severe depressive symptoms. Good internal consistency, stability, construct 
and concurrent validity of the PHQ-9 have been supported. 98,101 The standard published 
cut point of 10 was selected in this study for PHQ-9 to identify those in the sample who 
had moderate to severe depressive symptoms.28 This cut point was reported to have 88% 
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sensitivity and 88% specificity for diagnosing major depression.100,101 In this study, the 
Cronbach’s alpha of the PHQ-9 scale was 0.73. 
Anxiety 
The Brief Symptom Inventory (BSI) anxiety subscale was used to measure 
anxiety.102,103 The subscale consists of 6 questions, each of which is scored by patients 
using a scale that ranges from 0 (not at all) to 4 (extremely).  The total score is calculated 
as the mean of the 6 item scores. Thus, the possible range of scores for the anxiety scale 
is 0 to 4 with higher scores indicative of higher levels of anxiety. The BSI has 
demonstrated internal consistency, stability, construct and concurrent validity in other 
studies.102,103 In this study, the Cronbach’s alpha of the anxiety scale was 0.77. A 
standard published mean score of 0.35 was used to identify those in the sample who were 
anxious and those who were not anxious.104  
Demographic and clinical variables    
Data on demographic variables and clinical characteristics were collected by 
reviewing medical records and interviewing patients. These variables included age, 
gender, ethnicity, and NYHA class. The NYHA class indicates the level of functional 
impairment reported by patients as a result of symptoms and was rated by trained 
research nurses. These variables were selected because of their effects on the outcome 
variable as suggested in the literature.97,100 
Procedure 
Protocols for this study were approved by institutional review board of The 
University of Kentucky. All procedures were in accordance with institutional guidelines 
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for research using human subjects. Hospitalized patients were identified by clinicians and 
referred to research staff. The research staff determined the patient’s eligibility. The study 
was thoroughly explained to each patient and signed consent was obtained after 
answering any questions about the study. The research staff met with the patient to 
administer study questionnaires via the web based Survey Monkey. The questionnaires 
took approximately 20 minutes to complete. A paper copy also was offered to the patient 
if they did not feel comfortable with the web based survey.  
As a part of HOPE study, patient were contacted by phone to complete the follow 
up questionnaire at two weeks, three months, and six months from hospital discharge. At 
each telephone contact, the research staff asked the patient whether he or she has been 
hospitalized or visited the emergency unit. At the end of the study period and 
intermittently thereafter, hospital records were reviewed to confirm deaths, re-
hospitalizations or emergency department visits. 
Salivary samples were obtained for cortisol measurement in the morning at 
baseline at the time of questionnaires completion. All saliva samples were stored at -80ο 
C until analysis of samples at the University of Kentucky Dentistry Research laboratory. 
Statistical Analysis 
Data were analyzed using SPSS software, version 20.0 (SPSS Inc., Chicago, IL). 
Descriptive statistics, including mean, standard deviation and frequency distribution, 
were used to describe sample characteristics. To test Specific Aim 1, unadjusted, 
followed by adjusted, Cox regression analyses were used to determine whether stress, 
independently predicted event-free survival. The following covariates were considered in 
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the adjusted analysis and entered hierarchically: age, gender, NYHA class, and anxiety 
and depression. Demographic and clinical variables were entered first into the model. 
Then, anxiety and depressive symptoms were entered. Finally, stress as a continuous 
level variable was entered into the model. The same analysis was conducted using 
categorical level variables with the mean and median as cut-points. 
To test Specific Aim 2, linear and multiple regressions were used to determine the 
association of stress with salivary cortisol. This analysis included a sample of 70 patients 
because not all of the patients were able to provide a salivary sample. Two groups, low 
and high salivary cortisol level, were created based on the median of salivary cortisol 
level and used in this analysis. This analysis was conducted using both categorical and 
continuous level variables of salivary cortisol.  To test Specific Aim 3 using the same 
sample size (n=70), unadjusted Cox regression analysis was conducted to determine 
whether cortisol predicted event-free survival. Then, a hierarchal Cox regression analysis 
was used controlling to the following covariates: age, gender, and NYHA class. Again 
this analysis was conducted using both categorical and continuous level variables of 
salivary cortisol. The demographic and clinical variables were entered first and cortisol 
was entered second.  The assumptions of all Cox regressions, and linear and multiple 
regressions were tested for violations and none were noted. A p-value of ≤ 0.05 was 
considered statistically significant. 
Results 
Demographic and clinical characteristics of patients (N = 81) are summarized in 
Table 3.1. The average stress score in this sample was 9.47 ± 3.86, with a range of 4 to 
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20. No cut point has been defined for this instrument to date; however, the mean stress 
score in this study was higher than has been reported in other studies for the same 
scale.131,134,135 For example, in a study of college students the mean score was 5.6 ± 
3.6,131  and in a study of Chinese patients with cardiac conditions the mean was 6.0 ± 2.0 
135.  
The average anxiety score was 0.58 ± 0.68. Using the published BSI average in 
the general population of 0.35,104 46.7% scored as anxious. The average depressive 
symptoms score was 8.00 ± 4.87, and using the standard published PHQ-9 cut point 10,28 
29.6% of the sample was suffering from depressive symptoms. The average salivary 
cortisol level was 0.32 ± 0.23 ug/dL.   
Specific aim 1: Stress and the prediction of event-free survival 
A total of 28 (35%) patients had an event. Six (7.4%) died and 22 (27.2%) were 
hospitalized for cardiac reasons during the study. In the unadjusted model, stress (HR 
1.04; 95% CI: 0.95-1.13; p = 0.46) was not a predictor of event-free survival. In the 
adjusted model with age, gender, NYHA, anxiety, and depressive symptoms as 
covariates, the overall model (χ2 = 3.14, df. = 6; p =0.79) was not significant (Table 3.2). 
None of the variables were significant in any step of the hierarchal Cox regression. In the 
final model, stress (HR 1.06; 95% CI: 0.95-1.81; p = 0.32) was not a predictor of event 
free survival. An additional exploratory Cox regression analysis was conducted using 
stress as a categorical variable. The results were similar in that stress did not predict the 
outcome. 
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Specific aim 2: Association of stress and salivary cortisol 
The linear and multiple regressions (n = 70) showed that stress level was not a 
significant predictor of salivary cortisol (Tables 3.3 and 3.4). In addition, none of the 
covariate variables (age, gender, NYHA, and anxiety) in the multiple regression analysis 
was a significant predictor of salivary cortisol except age (HR 0.26; 95% CI: 0.00 – 0.01; 
p = 0.04) (Table 3.4). An additional exploratory Cox regression analyses was conducted 
using salivary cortisol as a categorical variable. The results were similar in that salivary 
cortisol did not predict the outcome. 
Specific aim 3: Salivary cortisol and the prediction of event-free survival 
In the Cox regression analysis, where salivary cortisol level was the independent 
variable (n=70), 24 patients (34.3%) had an event. Four (5.7%) of the participants died 
and 20 (28.6%) were hospitalized during the study. In an unadjusted model, salivary 
cortisol (HR 2.30; 95% CI: 0.99 – 5.93; p = 0.05) was a significant predictor of event free 
survival (Table 3.5 and figure 3.1). However, in the adjusted model with age, gender, and 
NYHA as covariates, the overall model (χ2 = 5.34, df. = 4; p =0.25) was not significant. 
None of the variables were significant in any step of the hierarchal Cox regression. In the 
final model, higher level of salivary cortisol (HR 2.03; 95% CI: 0.84 – 4.93; p = 0.12) 
was not a predictor of event-free survival (Table 3.6). An additional exploratory Cox 
regression analyses was conducted using salivary cortisol as a continuous variable. The 
results for both adjusted and unadjusted models were not significant.  
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Discussion 
Psychosocial factors such as depression, anxiety and lack of social support are 
associated with poor health outcomes in adults with HF.8,136 Clinicians and researchers 
commonly suggest that patients with HF have high levels of stress and that these levels of 
stress might contribute to poor outcomes.137 To the best of our knowledge, this is the first 
study to investigate stress and associated cortisol level as predictors of cardiac morbidity 
and all-cause mortality in patients with HF. Based on our literature review and the 
scientific background related to HF, stress, and morbidity and mortality, we hypothesized 
that stress and salivary cortisol would be a predictor of 6-month cardiac event-free 
survival. We also hypothesized a significant association between stress level and salivary 
cortisol level. None of these hypotheses were supported expect that salivary cortisol was 
a significant predictor of 6-month cardiac event-free survival in the unadjusted model 
only. Our findings suggest that stress level was not associated with cardiac 
rehospitalization and mortality among HF patients.  
Our hypotheses were based on the physiological mechanisms whereby stress may 
affect the progression of cardiovascular disease in general. Stress is thought to involve 
the hypothalamic–pituitary–adrenocortical (HPA). Much of the research on animals and 
humans suggests that psychological factors can influence the HPA axis, which controls 
the release of cortisol, a glucocorticoid that is secreted by the adrenal cortex to support 
and control physiological functions.59 Over the past decades, many investigators have 
concluded that physical and psychological stressors are capable of activating the HPA 
axis and increasing cortisol level in the blood stream.59 Through cortisol, the HPA 
supports physiological functions and regulates other systems. However, prolonged 
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elevation in cortisol due to frequent stress is associated with many negative biological 
effects such as suppression of the immune system, damage to hippocampal neurons, and 
development and progression of chronic diseases like diabetes and hypertension.52,63 In 
HF, cortisol may contribute to the progression of cardiac damage by acting as a 
mineralocorticoid receptor (MR) agonist in the cardiac muscle where cortisol mimics the 
physiological and pathophysiological effects of aldosterone.64-67 Given these data, it is 
crucial to determine whether the stressors that are associated with HF activate the cortisol 
system and contribute to the onset or exacerbation of certain health outcomes.  
Although there is evidence suggesting a relationship between stress and poor 
outcomes in cardiac patients without HF, the overall picture presented by the literature is 
one of conflicting findings.138 Stress, variably defined as psychological, psychosocial and 
mental stress, has been shown to predict mortality and morbidity in patients with 
cardiovascular diseases.139-141 Others, with large sample sizes, have found no association 
between stress level and increased admission rates related to cardiovascular disease.142 In 
fact, some of these investigators demonstrated an inverse relationship between stress and 
all-cause mortality, as well as cardiac mortality.142 Other investigators have demonstrated 
a difference between men and women in the prediction of mortality by stress in 
hospitalized medical patients.50, 51 Stress in male patients predicted all-cause mortality; 
however, no association was found between stress and mortality among women.143,144 
Investigators explained those results by stating that men are more vulnerable to stress 
than women. In addition, they expressed concerns that use of the two-question short 
version of the perceived stress scale did not capture some aspects of the stress 
phenomena.143,144    
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Our neutral finding about the relationship between stress and outcomes may be 
related to our small sample size, yet other investigators with very large sample sizes have 
similarly failed to find an association.142 Although patients in our sample had a higher 
stress level compared to other populations,131,135 the average score on the stress 
instrument was only moderately high. Thus, it may be that patients in this sample did not 
experience a stress level high enough to demonstrate the hypothesized relationship.  
Another potential explanation for our finding is that the instrument did not adequately 
capture stress. We used the 4-item perceived stress scale, which has been demonstrated to 
be valid and reliable; nonetheless, the full instrument may have provided more complete 
information about stress level than the short version.131,135,145 The 6 month follow up 
period may have been too short to capture the effect of stress on the health outcomes in 
patients with HF. Another possible explanation is that there is no relationship between 
stress level and outcomes in patients with HF. This explanation is supported by the 
number of investigations in which no relationship has been found in patients with a 
variety of health conditions.142,146,147 A final possible explanation is that there is an 
indirect association of stress with outcomes that is mediated through another construct 
such as coping. 
We found no association between stress level and salivary cortisol level. Our 
findings are consistent with a study of breast cancer patients that showed no significant 
relationship between stress and salivary cortisol level.148 Our study was similar to this 
study of breast cancer patients in that medically ill individuals with conditions that may 
be stressful were studied.  In a literature review 149 designed to evaluate salivary cortisol 
as a biomarker of self-reported mental stress in field studies of healthy adults, the authors 
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examined 14 studies published in medium or high quality journals. Results from eight 
studies demonstrated no association between self-reported mental stress and cortisol 
response, in 4 studies there was a positive association, and in 2 studies a negative 
association.149 They concluded that in healthy adults, there were insufficient data to 
support a relationship and postulated that the association, if present, might only be 
evident in those with extremely high levels of stress.  There are no other reviews more 
relevant to our sample of HF patients, but the suggestion that patients may need to 
experience very high levels of stress for the association to become evident is valid to our 
sample. 
Our finding showed an association between salivary cortisol level and all-cause 
mortality in patients with HF in the unadjusted model which is consistent with those of 
Yamaji and colleagues 150 who found that serum cortisol levels were a predictor of 
cardiac events patients with chronic HF. However, in the adjusted model that association 
was no longer significant. Similarly, others have found no such relationship between 
cortisol and acute coronary events among patients with acute coronary syndrome.151 The 
investigators relate their negative results to the interruption in cortisol rhythms during 
hospitalization, and this explanation may be relevant to our sample. 
Study strengths and limitations 
Strengths of our study include use of valid and reliable instruments to measure 
stress, salivary cortisol, and other covariates. Furthermore, we investigated multiple 
associations in this study that will form a foundation for future research in the field who 
are interested in stress and its effect on health outcomes in patients with HF.  
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The sample size of our study was a limitation that may have hindered our ability 
to demonstrate potential associations. As previously noted, however, a failure to find 
these associations has been noted in several studies with much larger sample sizes. The 
use of the 4-item perceived stress scale may limit the amount of information that we are 
able to collect related to stress; however, we used strict protocols and reliable and valid 
instruments for patients with HF.107-110  
 
 
Conclusion 
Our findings suggest that there is no relationship between stress level, as 
measured using the 4-item Perceived Stress Scale, and cardiac rehospitalization and all-
cause death in patients with HF. Our findings also suggest that in the setting of HF, a 
condition that produces high levels of background physiological stress, there is no 
association between self-reported stress and salivary cortisol. Before these findings can 
be accepted, future studies among HF patients with higher levels of stress and in larger 
sample sizes must be conducted. 
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           Note: CI = confidence interval, HF = heart failure, NYHA = New York Heart Association. 
  
Table 3.1: Sample Characteristics (N = 81) 
Characteristic N (%) OR MEAN ± SD 
Age, years 58.07 ± 13.07 
Anxiety score 0.58 ± 0.63 
Depressive symptoms score 8.00 ± 4.87 
Stress Score 9.47 ± 3.86 
Cortisol level,  ug/dL  (N = 70) 0.32 ± 0.23 
Gender 
  Male 
  Female 
 
43 (53.1) 
46 (46.9) 
Ethnicity 
  Caucasian 
  African American 
 
62 (76.5) 
19 (23.5) 
NYHA class 
   I/II 
   III/IV 
 
39 (48.1) 
42 (51.9) 
Stress 
  Not Stressed 
  Stressed 
 
42 (51.9) 
39 (48.1) 
Anxiety 
    Not Anxious  
    Anxious 
 
44 (54.3) 
37 (45.7) 
Depression 
   None/ Mild Depression 
   Moderate/ Severe  
 
57 (70.4) 
24 (29.6) 
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           Note: CI = confidence interval, HF = heart failure, NYHA = New York Heart Association. 
 
 
 
 
 
 
 
 
Table 3.2: Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Cardiac Event-free Survival (Stress Model) 
Predictor Variables Hazard Ratio    95% CI       P  
 
 Age  
 Female Gender  
NYHA class  III/IV compared to I/II  
 
1.01 
0.92 
0.70 
 
0.98 – 1.04 
0.43 – 1.98                   
0.29 – 1.47 
 
0.57 
0.84 
0.30 
Anxiety 
Depression 
Stress 
0.70 
1.07 
1.06 
0.30 – 1.52 
0.97 – 1.18 
0.95 – 1.18 
0.68 
0.19 
0.32 
Final Model Overall Model (χ2 = 3.14, df. = 6; p =0.79) 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.3: Linear Regression of  Stress Level Associated with Salivary Cortisol of Patients 
with Heart Failure 
Predictor Variable β    95% CI       P  
Stress -0.06 -0.02 – 0.01 0.60 
Overall Model (Adjusted R2 = -0.01, F=0.28; P= 0.60) 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association. 
 
 
 
 
 
 
 
 
 
Table 3.4: Multiple Linear Regression of Variables Associated with Salivary Cortisol of 
Patients with  Heart Failure 
Predictor Variables β 95% CI P 
 
 Age  
 Female Gender  
NYHA class  III/IV compared to I/II  
 
0.26 
-0.20 
0.15 
 
0.00 – 0.01 
-0.25 – 0.03 
-0.07 – 0.23 
 
0.04 
0.11 
0.27 
Anxiety 
Stress 
-0.002 
-0.09 
-0.12 – 0.12 
-0.03 – 0.01 
0.99 
0.55 
 Overall Model (Adjusted R2 = 0.056, F=1.769; P= 0.133) 
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Note: CI = confidence interval, NYHA = New York Heart Association. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5:  Unadjusted Cox Proportional Hazards Regression Model of Variables 
Associated with Cardiac Event-free Survival ( Salivary Cortisol Model) 
Predictor Variables Hazard Ratio 95% CI P 
 
High Cortisol Level  compared to Low level 
 
     2.30 
 
0.99 – 5.927 
 
0.05 
 Overall Model (χ2 = 4.00, df. = 1; p =0.45) 
54 
 
 
Note: CI = confidence interval, NYHA = New York Heart Association. 
 
 
 
 
 
 
 
 
 
Table 3.6:  Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Cardiac Event-free Survival ( Salivary Cortisol Model) 
Predictor Variables Hazard Ratio 95% CI P 
 
 Age  
 Female Gender  
NYHA class  III/IV compared to I/II  
 
1.01 
0.64 
0.74 
 
0.97 – 1.04 
0.27 – 1.52 
0.33 – 1.65 
 
0.69 
0.31 
0.50 
High Cortisol Level  compared to Low level 2.03 0.84 – 4.927 0.12 
 Overall Model (χ2 = 5.34, df = 4; p =0.25) 
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CHAPTER FOUR 
Introduction 
Heart failure (HF) is costly condition with high mortality and morbidity rates.5,152 
In 2012, the total costs for HF were around $31 billion, and this amount will rise to 
around $70 billion by 2030.6 Although biological factors contribute to the high morbidity 
and mortality in HF, there are many unexplored psychosocial factors that also likely 
contribute to the poor prognosis.9,10  
Heart failure is commonly perceived as stressful and thus associated with 
considerable psychological distress.11-15 Based on the literature to date, 10-15,44,45,70-72,77-
80,94, 81,82 a model of HF patients’ response to stressors is proposed (see Figure 1). 
Stressors have been defined as environmental circumstances or chronic conditions that 
are perceived by an individual as a threat to their physical and/or psychological health or 
well-being.42 Stressors may lead to a state in which an individual perceives that 
environmental demands exceed his or her ability to adapt to the situation43, this state is 
called stress. Stress is an umbrella term that is used to summarize the effect of 
unpredictable and seemingly uncontrollable events that may affect an individual’s 
physical and mental health. 44,45  
Chronic stress can stimulate the sympathetic nervous system and the 
hypothalamic–pituitary–adrenocortical axis (HPA) which may lead to negative biological 
effects such as suppression of the immune system, damage to hippocampal neurons, and 
development and progression of chronic diseases like diabetes and hypertension.52,63,153 
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Some researchers suggest that mental or psychological stress is associated with coronary 
artery diseases and sudden death,10,94 while others argue the connection between stress 
and these outcomes is less certain.138   
Considered in the context of HF, cognitive appraisal is a patient’s perception of an 
event or situation and their assessment of the degree to which the event is stressful. 
Cognitive appraisal also involves the patient’s assessment of the impact of the event on 
their personal goals and resources to manage stressor. 68,69 People have considerable 
differences in their appraisal of and response to stressors.154 Thus, cognitive appraisal is a 
core component of many stress models.59,68 Stressors can be apprised as: (1) irrelevant 
when the situation has no effect on the individual, (2) benign positive when the situation 
is evaluated as positive, or (3) or stressful.68  When appraised as stressful, the stressor can 
be further appraised as: (1) harm/loss resulting in damage to self or social esteem; (2) 
threat, which refers to suspected harm; or (3) challenge, which allows for the opportunity 
for gain and growth. 68 Cognitive appraisal has been shown to play an important role in 
determining the impact of the stress response. 70 Specifically, appraisal of a stressor in the 
harm/loss or threat categories resulted in poor health outcomes, impaired performance 
and lower quality of life. 71,72  In contrast, appraisal as a challenge has been associated 
with positive effects on cardiovascular reactivity and task engagement.71,72    
A patient’s cognitive appraisal of HF can predict their psychological and physical 
coping responses. 73 Lazarus and Folkman68 defined coping as “Constantly changing 
cognitive and behavioral efforts to manage specific external and/or internal demands that 
are appraised as taxing or exceeding the resources of the person.” Coping also includes 
cognitive or behavioral attempts to manage, master, or alter the stressful situation by 
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reducing it or by tolerating it.74,75 Two major types of coping have been suggested. 68 One 
type is emotion-focused coping, which describes the patient’s attempt to control his or 
her emotional response to the stressful situation. 68 It is used when the individual believes 
they cannot change the situation. 68,76  Examples of emotion focused coping include 
denial of the stressful situation, using drugs or alcohol to suppress anxiety about the 
stressful situation or seeking emotional support from others. The other type is problem-
focused coping, which occurs when the patient attempts to manage the stressful situation. 
68,76 
Emotion-focused coping includes a range of strategies that patients use to reduce 
or manage the emotional distress relating to stressful events.  These strategies can be 
divided into active emotional coping and avoidant emotional coping.77,78 Active 
emotional coping includes venting, positive reframing, humor, acceptance, and emotional 
support strategies. Avoidant emotional coping includes self-distraction, denial, behavioral 
disengagement, self-blame, and substance use.79,80 The predominant view of emotion-
focused coping is that it is a maladaptive form of coping associated with impaired health 
outcomes.81,82 In contrast, problem-focused coping contains cognitive and behavioral 
strategies aimed to alter or manage the stressor, such as planning, reaching out for 
instrumental support, and religion.79,80 Problem-focused coping is positively associated 
with better adjustment and health outcomes.82 According to Folkman, emotion-focused 
coping strategies are used in situations with high levels of uncertainty, in which the 
individual perceives few possibilities for effective beneficial change. In contrast, 
problem-focused coping strategies are used in situations in which the individual feels a 
sense of personal efficacy and perceives the possibility for making positive change.75 
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Among patients with HF, problem focused coping is associated with positive 
health-related quality of life and lower levels of depression. 82-85,88 In contrast, emotion 
focused is associated with a negative effect on health-related quality of life and a higher 
prevalence of depression.83-85 Avoidant emotional coping is also significantly associated 
with anxiety and poorer health patients with HF.86  Furthermore, avoidant emotional 
coping is associated with lower health-related quality of life in patient with head and neck 
cancer disease.87  
In a study conducted by Ransom et al.88, cancer patients, who focused on 
managing symptoms and seeking out information about their cancer, experienced more 
positive changes in their physical health and quality of life than those who focus on their 
emotions. 88 In another study on job stress, employees who used problem-focused coping 
experienced better job performance as compared with other employees who used 
emotion- focused coping.58 Moreover, when the stressful situation is perceived as a 
challenge versus a threat, problem-focused coping ensued, which led to better health 
outcomes. In contrast, threat, harm and loss cognitive appraisals are significantly 
correlated with emotional-focused coping, which leads to unsatisfactory health 
outcomes.71,89-93 
The purposes of this study were to describe self-reported stress level, cognitive 
appraisal and coping among patients with HF, and to examine the association of cognitive 
appraisal and coping strategies with event-free survival. 
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Method 
Design, sample, and setting 
A prospective design was used in which patients were followed for 6 months to 
determine occurrence of the combined endpoint of rehospitalization for cardiac causes or 
all-cause death. The study was a part of the Heart Outcomes Prevention Evaluation 
(HOPE) study at the University of Kentucky that investigated depression among 
hospitalized patients with HF. The parent study and the current study were approved by 
the Institutional Review Board at the University of Kentucky. The sample consisted of 88 
patients with HF who were hospitalized for cardiac reasons at the University of Kentucky 
Chandler Medical Center or Good Samaritan Hospital located in Lexington, Kentucky. 
These same data  were used to study the association of stress with morbidity and 
mortality in patients with HF.155 
Patients with a diagnosis of chronic HF were eligible for participation in the study 
if they were: a) admitted to the hospital with a primary or secondary diagnosis of 
exacerbation of chronic HF or any other cardiac diagnosis, b) 21 years or older, c) able to 
read and speak English, and d) not obviously cognitively impairment. Patients were 
excluded from the study for: a) co-existing terminal illness likely to be fatal within the 
next 6 months, b) presence of a left ventricular assist device, continuous inotropic 
infusion, or hospice care, c) active suicidality (defined as choosing option 2 or 3 on item 
9 of the Beck Depression Inventory-II), d) history of the death of a spouse or child within 
the past month, e) history of psychotic illness or bipolar illness, and f) current alcohol 
dependence or other substance abuse. 
61 
 
Measures 
Stress 
Stress was measured using the brief version of the Perceived Stress Scale.131 The 
original, longer version of the scale consists of 14-items that measure the degree to which 
patients appraised situations as stressful in the last month.131 The brief version consists of 
a four-item scale that has been demonstrated to be reliable and valid.131  Each item is 
rated by patients on a scale ranging from 0 (never) to 5 (very often). The four items are:  
(1) how often have you felt that you were unable to control the important things in your 
life?, (2) how often have you felt confident about your ability to handle your personal 
problems?, (3) how often have you felt that things were going your way?, and (4) how 
often have you felt difficulties were piling up so high that you could not overcome them? 
Higher scores indicate greater levels of stress. 
Coping  
Coping was measured using the Brief COPE scale.156 This 28-item scale is an 
abbreviated version of the COPE Inventory. It was modified from the full instrument 
because of the length and redundancy of the full instrument and because of the associated 
time burden.156 The scale's author has demonstrated the reliability and validity of the 
brief version in health related research through factor analysis and reliability testing.156 
The responses in this scale range from 1 (I haven’t been doing this at all) to 4 (I have 
been doing this a lot). This instrument has 14-subscales of two items each that reflects a 
variety of different coping methods (e.g., praying or meditating, receiving emotional 
support from others, criticizing oneself) with reliable psychometric properties.156 Based 
62 
 
on conceptual and empirical literature the 14- subscales were grouped in three coping 
strategies which are active emotional coping, avoidant emotional coping, and problem 
focused coping.45,68,157 Higher scores indicate that the patient used that coping strategy 
commonly. 
Cognitive Appraisal  
Cognitive appraisal was measured using the brief version of the Cognitive 
Appraisal Health Scale.158,159 This brief version contains 13 items derived from Kessler’s 
scale, which is one of the major measures of cognitive appraisal of stressful and non-
stressful events.69 Validity was supported by component factor analysis and reliability has 
been shown in previous studies.158,159 The responses in this scale range from 0 (strongly 
agree) to 5 (strongly disagree). Higher scores indicate that the patient does not commonly 
use that type of appraisal. 
Event-free survival 
Event-free survival was defined as the combined endpoint of cardiac 
rehospitalization or all-cause death.  Hospitalization data were determined through a 
combination of patient and family interviews and a review of medical records. 
Hospitalizations were verified and documented by trained research assistants who 
reviewed medical records and clinic notes on a weekly basis. Given the possibility that 
patients could have been hospitalized at different facilities, trained research assistants 
carefully questioned the patients or family members by phone to determine if 
hospitalization had occurred elsewhere. 
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All-cause mortality was determined by interview with the patient’s family, 
medical record review and review of county death records.  At enrollment, the patient 
was asked for contact information for a close friend or family member in case the patient 
could not be contacted. At follow-up if a patient could not be reached by phone, hospital 
records were searched. When information regarding the patient was not available, family 
members or friends were contacted.   If these contacts could not be reached, county death 
records were used to determine patient death. 
Demographic and clinical variables    
Data on demographic variables and clinical characteristics were collected by 
reviewing medical records and interviewing patients. These variables included age, 
gender, ethnicity, and New York Heart Association (NYHA) class. NYHA class 
indicated the level of functional impairment reported by patients as a result of symptoms 
and was determined by trained research nurses using a structured interview. These 
variables were selected because of their effects on the outcome variables as suggested in 
the literature.97,100 
Procedure 
Hospitalized patients were identified by clinicians and referred to research staff 
who determined each patient’s eligibility. The study was thoroughly explained to each 
patient and signed consent was obtained after answering any questions patients had about 
the study. Research staff discussed the voluntary nature of the study. The research staff 
met with the patient to administer study questionnaires via the web based Survey 
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Monkey. The questionnaires took approximately 20 minutes to complete. A paper copy 
was offered to the patient if they did not feel comfortable with the web based survey.  
As a part of HOPE study, patients were contacted by phone to complete the 
follow up questionnaires at two weeks, three months, and six months from hospital 
discharge. At each telephone contact, the research staff asked the patient whether he or 
she has been hospitalized or visited the emergency unit. At the end of the study period, 
hospital records were reviewed to confirm deaths, re-hospitalizations or emergency 
department visits. 
Statistical Analysis 
Data were analyzed using SPSS software, version 20.0 (SPSS Inc., Chicago, IL). 
Descriptive statistics, including means, standard deviations and frequency distributions, 
were used to describe sample characteristics. Two tailed Pearson correlation coefficients 
were used to determine bivariate relationship among the variables. Linear and multiple 
regressions were used to determine the association between stress and cognitive appraisal 
type, stress and coping style, and cognitive appraisal and coping style. Two groups, low 
and high perceived stress level, were created based on the mean of perceived stress level 
and used in this analysis. To examine the association of cognitive appraisal and coping 
strategies with event-free survival, unadjusted, followed by adjusted, Cox regression 
analyses were used to determine whether different types of cognitive appraisal and 
coping styles, independently predicted event-free survival. Each type of cognitive 
appraisal and each style of coping was entered in separate Cox regression analyses. The 
following covariates were considered in the adjusted analyses: age, gender, and NYHA 
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class. The assumptions of all Cox regressions, and linear and multiple regressions were 
tested for violations and none were noted. A p-value of ≤ 0.05 was considered 
statistically significant. 
Results 
Sample Characteristics   
Demographic and clinical characteristics of patients (N = 88) are summarized in 
Table 4.1. The average stress score in this sample was 9.44 ± 3.86, with a range of 4 to 
20. This mean is higher than reported in studies of college students the mean score was 
5.6 ± 3.6,131  and in Chinese cardiac patients the mean was 6.0 ± 2.0).131,134,135  The 
average cognitive appraisals scores were as following: threat appraisal 2.46 ± 0.87, 
challenge appraisal 2.47 ± 0.77, and harm/loss appraisal 2.65 ± 0.88. The possible range 
of cognitive appraisal score is between 0 and 5 and a higher score indicates less use of 
that type of cognitive appaisal. 158,159 The average coping styles scores were as follows: 
problem focused coping 2.82 ± 0.66, active emotional coping 2.57± 0.56, and avoidant 
emotional coping 1.56 ± 0.38. The range of coping style score is between 1 and 4, and a 
higher score indicate greater  use of that coping style. 156 A total of 29 (32.9%) patients 
had an event: seven (7.9%) died and 23 (25%) were hospitalized for cardiac reasons.  
Bivariate Correlations Among the Variables  
The two tailed Pearson correlations (Table 4.2) showed that harm/loss cognitive 
appraisal was significantly correlated with stress level (r= -0.342, p = 0.005). 
Specifically, higher levels of stress were associated with more common use of harm/loss 
appraisal. Stress level was also significantly correlated with avoidant emotional coping 
(r= 0.429, p < 0.001). Avoidant emotional coping style was associated with higher levels 
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of stress. In addition, threat cognitive appraisal was significantly correlated with 
harm/loss cognitive appraisal (r= 0.325, p = 0.008) and avoidant emotional coping (r= -
0.372, p = 0.002). Appraisal of HF as a threat was associated with avoidant emotional 
coping style, and appraisal of the condition as harm/loss. Furthermore, harm/loss 
cognitive appraisal was significantly correlated with challenge cognitive appraisal (r= -
0.324, p = 0.008) and avoidant emotional coping (r= -0.433, p < 0.001). When HF 
patients appraise their condition as harm/loss, they tend to use avoidant emotional coping 
style and are less likely to appraise their condition as a challenge. 
Prediction of Cognitive Appraisal  
In unadjusted analyses, and with regard to prediction of cognitive appraisal type 
using stress level, stress was not a significant predictor of challenge (β -0.10; 95% CI: -
0.23 – 0.54; p = 0.43) or threat (β -0.14; 95% CI: -0.69 – 0.19; p = 0.26) cognitive 
appraisals. However, stress was a significant predictor of harm/loss cognitive appraisal (β 
-0.3; 595% CI: -1.03 – -0.20; p = 0.01). High level of stress was associated with greater 
use of harm/loss cognitive appraisal.  
In adjusted analyses, and with regard to prediction of cognitive appraisal, multiple 
linear regressions showed that none of the demographic, clinical, or stress variables was a 
significant predictor of challenge (Table 4.3). The only significant predictors of cognitive 
appraisal as threat were age (β 0.39; 95% CI: 0.01 – 0.04; p = 0.01) and gender (β -0.23; 
95% CI: -0.81– 0.01; p = 0.05; Table 3). Specifically, older age and female gender were 
associated with cognitive appraisal as threat. Finally, age (β 0.06; 95% CI: -0.01 – 0.02; p 
= 0.05) and stress (β -0.37; 95% CI: -1.11 – -0.23; p < 0.001) were the only significant 
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predictors of cognitive appraisal as harm/loss (Table 4.3). Specifically, older age and 
higher stress level were associated with harm/loss cognitive appraisal.  
Prediction of Coping Style 
In unadjusted analyses, and with regard to prediction of coping style, none of the 
cognitive appraisal styles was a significant predictor of problem focused coping style 
which was as follows: challenge cognitive appraisal (β -0.09; 95% CI: -0.31 – 0.17; p = 
0.55), threat cognitive appraisal (β -0.14; 95% CI: -0.32 –0.11; p = 0.32), and harm/loss 
cognitive appraisal (β -0.01; 95% CI: -0.23 – 0.21; p = 0.94). In addition, none of the 
cognitive appraisal styles was a significant predictor of active emotional coping style 
which was as follows: challenge cognitive appraisal (β 0.08; 95% CI: -0.15 – 0.26; p = 
0.59), threat cognitive appraisal (β -0.11; 95% CI: -0.26 – 0.12; p = 0.45), and harm/loss 
cognitive appraisal (β 0.04; 95% CI: -0.16 – 0.21; p = 0.80). Finally, harm/loss cognitive 
appraisal (β -0.35; 95% CI: -0.25 – -0.03; p = 0.01) was a significant predictor of 
avoidant emotional coping style. However, challenge (β -0.20; 95% CI: -0.12 – 0.11; p = 
0.88) and threat cognitive (β -0.23; 95% CI: -0.20 – 0.10; p = 0.08) appraisals were not 
significant predictors of avoidant emotional coping. 
In adjusted analyses, and with regard to prediction of coping style, harm/loss 
cognitive appraisal (β -0.28; 95% CI: -0.21 – -0.02; p = 0.02) and stress level (β 0.29; 
95% CI: 0.04– 0.38; p = 0.02) were significant predictors of avoidant emotional coping 
controlling for age, gender, and NYHA class (Table 4.4). Higher levels of stress and 
greater use of harm/loss cognitive appraisal were associated with avoidant emotional 
coping style. Neither challenge (β -0.05; 95% CI: -0.14 – 0.09; p = 0.72) nor threat (β -
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0.15; 95% CI: -0.18– 0.06; p = 0.30) cognitive appraisals were significant predictors of 
avoidant emotional coping (Table 4.4). None of the demographic, clinical, stress, or 
cognitive appraisal variables was associated with active emotional coping style or 
problem focused coping style in adjusted regression analyses (Tables 4.5 and 4.6). 
Prediction of Event-Free Survival  
Using Cox regression to predict death and cardiac rehospitalization from 
cognitive appraisal, and in unadjusted analyses, only harm/loss cognitive appraisal was 
associated with event-free survival (HR 0.51; 95% CI: 0.22 – 0.89; p = 0.02). 
Specifically, greater use of harm/loss cognitive appraisal predicted shorter event-free 
survival.  Using Cox regression to predict death and cardiac rehospitalization from 
coping style, and in unadjusted analyses, the only significant coping style associated with 
event-free survival was avoidant emotional coping style (HR 2.53; 95% CI: 1.07 – 6.00; 
p = 0.04). Specifically, greater use of avoidant emotional coping style was associated 
with shorter event-free survival.  
In analyses adjusted for age, gender and NYHA class, where cognitive appraisal 
types were the independent variables, none of the demographics, clinical characteristics, 
or cognitive appraisal variables was significant predictors of event-free survival (Table 
4.7). Where coping styles were the independent variables, none of the demographics, 
clinical characteristics or coping styles were significant predictors (Table 4.8).  
Discussion 
Despite the medical and surgical advances in HF treatment, mortality and 
morbidity rates are still substantial even in comparison to some aggressive types of 
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cancer. 3,4,7,8 Biological factors explain some of this high morbidity and mortality.160-164 
There are, however, many psychosocial factors that may contribute to high morbidity and 
mortality rates and that remain relatively unexplored in patients with HF, including stress, 
cognitive appraisal, and coping style. 9,10 We hypothesized the relationships among the 
study variables (stress, cognitive appraisal, and coping) depicted in the model (Figure 1) 
that was developed based on the literature to date. 10-15,44,45,70-72,77-80,94, 81,82  
Based on the model, we hypothesized that stress level would be a predictor of 
type of cognitive appraisal. The only type of cognitive appraisal that was predicted by 
stress level was harm/loss cognitive appraisal. Higher stress levels were associated with 
greater use of harm/loss cognitive appraisal.  This finding suggests that patients with HF 
respond negatively to higher stress levels with an appraisal type that is associated with 
negative health outcomes, and are unable to marshal a positive coping response to stress. 
In some populations, patients have demonstrated the ability to respond to the stress 
imposed by their condition with a healthier type of cognitive appraisal, challenge, which 
is associated with better adherence and outcomes. 70-72 
We further hypothesized that cognitive appraisal type would be a predictor of 
coping style. Only stress and harm/loss cognitive appraisal were predictors of avoidant 
emotional coping style. Our findings suggest that higher levels of stress and greater use 
of harm/loss cognitive appraisal were associated with avoidant emotional coping style. 
Thus, the dominant type of cognitive appraisal in our sample of patients with HF is 
associated with a coping style that has negative health outcomes and a negative impact on 
emotional well-being. 
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Furthermore, we hypothesized that coping style would predict 6-month event-free 
survival. In the unadjusted model, avoidant emotional coping was a significant predictor 
of 6-month event-free survival, but it was not an independent predictor. This finding 
suggests that in the company of other variables, coping style is a less important predictor 
of outcomes. We also investigated whether cognitive appraisal type predicted 6-month 
event-free survival. Our findings suggest that greater use of harm/loss cognitive appraisal 
predicted shorter event-free survival in HF. None of the other cognitive appraisal types 
were significant predictors. Taken together, our findings suggest that the usual type of 
appraisal and coping used by patients with HF in response to stress, which is common 
among them, should be avoided. Healthcare providers must assist patients to learn and 
use more positive types of appraisal and coping in response to stress.  Cognitive 
behavioral therapy is effective in assisting patients assume healthier appraisal and coping 
strategies, which are associated with better health outcomes, greater self-efficacy, and 
less depression and anxiety.165,166 
  In a study conducted among patients with the human immunodeficiency virus, 
psychological stress was associated with threat cognitive appraisal.167 Our findings 
suggest that HF patients may have different appraisal for the stressful situation since 
higher level of stress was associated with harm/loss cognitive appraisal. However, these 
findings demonstrate that cognitive appraisal plays a role in the stress response.70  
In addition, cognitive appraisal plays a significant role determining the coping 
style used by HF patients. In an Israeli’s study conducted among immigrants from the 
Soviet Union, threat and harm/loss cognitive appraisal were associated with avoidant 
emotional coping that was negatively related to the adaptation to the immigration 
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situation. On the other hand, challenge cognitive appraisal was associated with problem 
focused coping that was positively related to the adaptation to new immigration 
situation.168 Our findings suggest that HF patients, who appraise their condition as 
harm/loss, tend to use avoidant emotional coping style that is associated with negative 
health outcomes across literature. 83-87 Unfortunately HF patients in our sample, seem 
unable to respond with the more positive appraisal and coping styles.  
In a study conducted among chronic pain patients, threat and harm/loss cognitive 
appraisals were associated with passive coping styles such as avoidant coping. In 
addition, passive coping styles were associated with higher levels of pain.91 On the other 
hand, challenge cognitive appraisal was associated with problem focused coping that was 
associated with lower levels of pain.91 Our findings were similar to those findings as 
threat and harm/loss cognitive appraisal was associated with avoidant emotional coping 
style that predicted all-cause mortality and cardiac rehospitalization among HF patients in 
the unadjusted model. Another study conducted on melanoma survivors showed that 
cognitive appraisals such as threat and harm/loss were associated with poor adjustment, 
high distress, and reduction of well-being in melanoma patients. However, challenge 
cognitive appraisal, which is considered a healthier appraisal type was associated with 
ability to adjust, reduce distress, higher well-being of melanoma patients.169  
Our study was the first to investigate stress, cognitive appraisal, coping, and 
event-free survival in HF patients. Many of our findings were consistent with other 
investigations conducted on different groups of healthy and ill subjects. 91,167-169 
However, we did not find hypothesized associations in our model from the literature. 
These findings may be related to small sample size. Another potential explanation is that 
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the instruments did not adequately capture stress and coping styles. We used brief stress 
and coping scales that contains 4 and 28 items respectively. Both shortened measures 
have been demonstrated to be valid and reliable; nonetheless, the full instruments may 
have provided more complete information about stress level, and coping styles than the 
shorter versions. 131,135,145,156. Another potential explanation is that the 6 month follow up 
period may have been too short to capture the effect of coping styles on the health 
outcomes in patients with HF. A final possible explanation is that there is no relationship 
between the variables and outcomes in patients with HF. 
Study Strengths and Limitations 
Strengths of our study include the use of valid and reliable instruments to measure 
stress, cognitive appraisal, coping, and other covariates. Furthermore, we investigated 
multiple associations among the variables of this study and our findings form a 
foundation for future studies of stress, cognitive appraisal, coping, and health outcomes 
in HF patients. 
The small sample size is one of the limitation of this study that may affect our 
ability to find significant association similar to those that been presented in the literature. 
In addition, the use of brief versions of stress and coping scales may affect our ability to 
capture the proper stress level and coping styles in a way that allow us to find significant 
associations; however, we used strict protocols and reliable and valid instruments for 
patients with HF.107-110  
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Conclusion 
Our findings suggest that there is an association between stress level and 
harm/loss cognitive appraisal that is associated with shorter event free survival among HF 
patients. In addition, harm /loss cognitive appraisal is associated with avoidant emotional 
coping that is associated with negative health outcomes and shorter event-free survival. 
Thus, to improve health outcomes in patients with HF, interventions are needed to the 
reduce stress of HF and change how HF patients appraise their condition and cope with it. 
Cognitive restructuring may be useful among patients with HF who negatively appraise 
the stress of HF as such appraisal leads to negative coping strategies that are associated 
with worse event-free survival. 
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Note: CI = confidence interval, HF = heart failure, NYHA = New York Heart Association. 
Table 4.1: Sample Characteristics (N = 88) 
Characteristic N (%) OR MEAN ± SD 
Age, years 58.13 ± 12.64 
Stress Score 9.44 ± 3.86 
Cognitive appraisal 
  Threat Score 
  Challenge Score 
  Harm/Loss Score 
2.46 ± 0.87 
2.47 ± 0.77 
2.65 ± 0.88 
Coping Style 
  Problem Focused Coping Score 
  Active Emotional Coping Score 
  Avoidant Emotional Coping Score 
2.82 ± 0.66 
2.57± 0.56 
1.56 ± 0.38 
Gender 
  Male 
  Female 
47 (53.4) 
41 (46.6) 
Ethnicity 
  White 
  African American 
68 (77.3) 
20 (22.7) 
NYHA class 
   I/II 
   III/IV 
40 (45.5) 
48 (54.5) 
Stress 
  Not Stressed 
  Stressed 
47 (53.4) 
41 (46.6) 
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Table 4.2. Bivariate Correlations Among Stress, Coping, and Cognitive Appraisal 
Variables 
Variables Stress Threat 
Appraisal 
Harm/Loss 
Appraisal 
Challenge 
Appraisal 
Active 
Emotional 
Coping 
Avoidant 
Emotional 
Coping 
Problem-
Focused 
Coping 
Stress        
Threat 
Appraisal 
r= -0.131 
P= 0.296 
      
Harm/Loss 
Appraisal 
r= -0.342 
p=0.005 
r= 0.325 
P= 0.008 
     
Challenge 
Appraisal 
r=0.096 
P=0.443 
r= 0.110 
P= 0.383 
r= -0.324 
P= 0.008 
    
Active 
Emotional 
Coping 
r=0.042 
P=0.739 
r= -0.115 
P= 0.360 
r= -0.045 
P= 0.724 
r= 0.035 
P= 0.779 
   
Avoidant 
Emotional 
Coping 
r= 0.429 
P <0.001 
r= -0.372 
P= 0.002 
r= -0.433 
P <0.001 
r= 0.054 
P= 0.674 
r= 0.125 
P= 0.321 
  
Problem-
Focused 
Coping 
r= 0.061 
P=0.628 
r= -0.152 
P= 0.235 
r= -0.027 
P= 0.836 
r= -0.141 
P= 0.272 
r= 0.536 
P< 0.001 
r= 0.021 
P= 0.873 
 
Note: r = two tailed Pearson correlation, p = two tailed significance level 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association 
Table 4.3:   Multiple Linear Regression of Variables Associated with Cognitive Appraisal 
Type. 
Predictor Variables β 95% CI P 
Challenge Cognitive Appraisal 
  Age 
  Female Gender 
 NYHA class  III/IV compared to I/II 
0.06 
0.08 
-0.18 
-0.01 – 0.02 
-0.29 – 0.52 
-0.70 – 0.13 
0.68 
0.57 
0.18 
 High stress level compared to low stress level 0.13 -0.21 – 0.62 0.32 
 Overall Model (Adjusted R2 = -0.02, F=0.665; P= 0.619) 
Threat Cognitive Appraisal 
 Age 0.39 0.01 – 0.04 0.01 
 Female Gender       -0.23 -0.81– 0.01 0.05 
 NYHA class  III/IV compared to I/II 0.24 0.01– 0.83 0.46 
 High stress level compared to low stress level    -0.06 -0.52– 0.31 0.61 
Overall Model (Adjusted R2 = 0.215, F=5.173; P= 0.001) 
Harm/loss Cognitive Appraisal 
 Age 0.06 -0.01 – 0.02 0.05 
 Female Gender       0.01 -0.42 – 0.46 0.91 
 NYHA class  III/IV compared to I/II 0.20 -0.09 – 0.81            0.12 
 High stress level compared to low stress level                 -0.37 -1.11 – -0.23         <0.001 
Overall Model (Adjusted R2 = 0.126, F=3.190; P= 0.020) 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association 
Table 4.4: Multiple Linear Regression of Variables Associated with Avoidant Emotional 
Coping of Patients with  Heart Failure 
Predictor Variables β 95% CI P 
 Age 
 Female Gender 
NYHA class  III/IV compared to I/II 
-0.15 
0.13 
-0.15 
-0.01 – 0.00 
-0.10 – 0.25 
-0.27 – 0.06 
0.20 
0.25 
0.19 
High stress level compared to low stress level 
Harm/loss cognitive appraisal 
Threat cognitive appraisal 
Challenge cognitive appraisal 
0.30 
-0.28 
-0.15 
-0.05 
0.04 – 0.38 
-0.21 – 0.02 
-0.12– 0.06 
-0.14– 0.10 
0.02 
0.02 
0.30 
0.72 
 Overall Model (Adjusted R2 = 0.26, F=5.425; P< 0.001) 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association 
Table 4.5: Multiple Linear Regression of Variables Associated with Active Emotional 
Coping of Patients with  Heart Failure 
Predictor Variables β 95% CI P 
 Age 
 Female Gender 
NYHA class  III/IV compared to I/II 
0.07 
0.12 
-0.13 
-0.01 – 0.01 
-0.18 – 0.45 
-0.47 – 0.18 
0.66 
0.85 
0.38 
High stress level compared to low stress level 
Harm/loss cognitive appraisal 
Threat cognitive appraisal 
Challenge cognitive appraisal 
0.05 
0.04 
-0.06 
0.05 
-0.26 – 0.38 
-0.18 – 0.23 
-0.25– 0.17 
-0.18– 0.25 
0.72 
0.82 
0.70 
0.72 
 Overall Model (Adjusted R2 = 0.04, F=0.34; P= 0.932) 
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Note: CI = confidence interval, β = adjusted regression slope coefficient, NYHA = New York Heart Association 
Table 4.6: Multiple Linear Regression of Variables Associated with Problem-Focused 
Coping of Patients with  Heart Failure 
Predictor Variables β 95% CI P 
 Age 
 Female Gender 
NYHA class  III/IV compared to I/II 
0.14 
0.07 
-0.07 
-0.01 – 0.02 
-0.27 – 0.46 
-0.46 – 0.28 
0.35 
0.61 
0.63 
High stress level compared to low stress level 
Harm/loss cognitive appraisal 
Threat cognitive appraisal 
Challenge cognitive appraisal 
0.06 
-0.00 
-0.15 
-0.10 
-0.30 – 0.46 
-0.24 – 0.24 
-0.36– 0.13 
-0.34– 0.16 
0.67 
0.99 
0.35 
0.49 
 Overall Model (Adjusted R2 = 0.06, F=0.483; P= 0.842) 
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Note: CI = confidence interval, NYHA = New York Heart Association 
Table 4.7:  Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Cardiac Event-free Survival ( Cognitive Appraisal Model) 
Predictor Variables Hazard Ratio 95% CI P 
 Age 
 Female Gender 
NYHA class  III/IV compared to I/II 
1.02 
0.84 
0.86 
0.98 – 1.06 
0.32 – 2.24 
0.33 – 2.23 
0.35 
0.73 
0.76 
Harm/loss cognitive appraisal 
Threat cognitive appraisal 
Challenge cognitive appraisal 
0.53 
0.89 
1.14 
0.28 – 1.02 
0.49 – 1.60 
0.59 – 2.18 
0.05 
0.69 
0.70 
 Overall Model (χ2 = 7.56, df = 7; p =0.48) 
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Note: CI = confidence interval, NYHA = New York Heart Association 
Table 4.8:  Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Cardiac Event-free Survival ( Coping Styles Model) 
Predictor Variables Hazard Ratio 95% CI P 
 Age 
 Female Gender 
NYHA class  III/IV compared to I/II 
1.02 
0.76 
0.74 
0.98 – 1.07 
0.31 – 1.83 
0.29 – 1.87 
0.37 
0.54 
0.52 
Problem Focused Coping 
Active Emotional Coping 
Avoidant Emotional Coping 
1.98 
0.91 
3.23 
0.92 – 4.25 
0.39 – 2.11 
1.14 – 9.16 
0.08 
0.83 
0.03 
 Overall Model (χ2 = 7.97, df = 6; p =0.24) 
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Figure 4.1.  Proposed model of heart failure patients’ response to stressors based on 
literature to date. 
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CHAPTER FIVE 
Conclusions and Discussion 
Heart failure is a major health problem that is responsible for some of the highest 
mortality and hospitalization rates in the world.2,111-118 Patients with HF experience 
multiple changes in their heart structure and function that affect the ability of cardiac 
ventricles to fill with, or eject, blood. 1  In addition, patients with HF experience many 
psychological symptoms that may contribute to additional physiological changes and 
affect survival. 9-16,20-23  In the United States, HF and sudden death combined are 
accountable for the largest number of deaths. 4,5  Furthermore, HF is the leading cause of 
hospitalization and discharge among adults patient older than 65, with substantial 
increases in hospitalization and discharge rates seen every year. 2,6 The total estimated 
cost of HF in the United States is $37 billion with an expected increase of $2 billion each 
year. 2,6  Although there have been significant medical and surgical advancements in HF 
treatment, mortality and hospitalizations rates continued to increase every year. 3,4 The 
pathophysiology of HF explains a major part of these high rates, however, there are many 
unexplored psychosocial factors that also likely contribute to poor prognosis such as 
comorbid depression and anxiety, stress, cognitive appraisal, and coping. 
Depression is a major mood disorder that is highly prevalent in HF and is 
associated with multiple unhealthy behaviors. 16,17,20,12,22,23Anxiety is a negative emotion 
state that is associated with adverse cardiac events and progression of disease. 10,16 
Anxiety also is highly prevalent in patients with HF.12 Depression and anxiety are 
independently associated with survival among HF patients. 10,16,21  
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 Whether co-morbid symptoms of anxiety and depression are associated with 
outcomes in patients with HF is unknown. The purpose of chapter two was to examine 
whether co-morbid symptoms of depression and anxiety are associated with all-cause 
mortality or rehospitalization for cardiac causes in patients with HF. We found that 
comorbid depression and anxiety predicted all–cause mortality when treated at both the 
categorical and continuous levels. However, comorbid depression and anxiety was not a 
significant predictor of cardiac rehospitalization when treated as categorical or 
continuous level. The study presented in chapter two continued the work of other 
investigators such as Frasure-Smith and colleagues,105 and Doering and colleagues106 who 
examined the comorbid effect of depressive and anxiety symptoms in patients with heart 
disease, but without HF. IN addition to being the first investigation of this type in patients 
with HF, our findings filled some of the gaps in previous work by using valid and reliable 
measures to assess depressive and anxiety symptoms, controlling for age and disease 
severity, addressing rehospitalization, and considering the impact of variables treated at 
both the categorical and continuous levels. Our findings highlighted the hazardous effect 
of comorbid depressive and anxiety symptoms on the mortality rate of adults with HF. In 
addition, our findings suggest that psychological factor plays an important role in the 
mechanism of high mortality rate in HF patients. 
Because depressive and anxiety symptoms usually develop after stressful life 
events that are not cognitively processed in a healthy way35 and because HF is considered 
a substantial stressor for many patients, 11,12  examination of the role of stress on health 
outcomes in patients with HF is important. Thus, chapter three of this dissertation aimed 
to (1) examine the association of stress with 6-month cardiac event-free survival, 
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controlling for anxiety, depression, and New York Heart Association (NYHA) functional 
class; (2) examine the relationship of stress with salivary cortisol; and (3) examine the 
association of salivary cortisol level with 6-month cardiac event-free survival, controlling 
for age, gender, and NYHA class. 
Stress can be defined as a condition where the environmental demands exceed the 
individual’s ability to adapt to these demands. 43  This definition can be applied to HF as 
a stressor that may lead to a stress state if patients’ abilities are unable to meet the 
environmental demands associated with HF. We hypothesized that stress and salivary 
cortisol would be predictors of event-free survival in HF patients. In addition, we 
hypothesized that stress would be a predictor of salivary cortisol level in HF patients. 
Our findings showed that none of these hypotheses were supported expect that 
salivary cortisol was a significant predictor of 6-month cardiac event-free survival in the 
unadjusted model only. Our only result consistent with our hypotheses was the 
association between salivary cortisol level and all-cause mortality in patients with HF in 
the unadjusted model which been presented in other studies such as Yamaji and 
colleagues.150  However, this relationship was no longer significant in the adjusted model. 
Our results regarding the relationship between stress and event-free survival and 
between stress and salivary cortisol were consistent with other investigators’ findings 
who conducted their study with larger samples in different populations. 142,148  However, 
the short follow up period and the abbreviated stress scale we used may have contributed 
to inability to capture the possible effect of stress on health outcomes in HF patients. 
Another possible explanation is that the relationship between stress and health outcomes 
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in HF patients may present but in indirect way through other variables such as cognitive 
appraisal and coping. 
Therefore, in another study presented in chapter four we examined the 
relationships of stress, cognitive appraisal, coping style, with health outcomes presented 
in Figure 1, which is a proposed model of HF patients’ response to stressors based on the 
literature to date. 10-15,44,45,70-72,77-80,94, 81,82 
Cognitive appraisal can be defined as patients’ perceptions of an event or a 
situation and to degree to which this event or situation is viewed as stressful to the 
patient. 68,69  Any event or situation can be appraised as (1) irrelevant when the situation 
has no effect on the individual, (2) benign positive when the situation is evaluated as 
positive, or (3) or stressful.68 When appraised as stressful, the stressor can be further 
appraised as: (1) harm/loss resulting in damage to self or social esteem; (2) threat, which 
refers to suspected harm; or (3) challenge, which allows for the opportunity for gain and 
growth. 68 The cognitive appraisal process plays a major role in the stress response and 
coping process. 70 Coping can be defined as “Constantly changing cognitive and 
behavioral efforts to manage specific external and/or internal demands that are appraised 
as taxing or exceeding the resources of the person.” 68 Coping strategies can be divided in 
three categories: active emotional coping, avoidant emotional coping, and problem-
focused coping. 68,77,78 The major view of emotion-focused coping is that it is a 
maladaptive form of coping associated with impaired health outcomes.81,82 Problem-
focused coping is usually associated with better adjustment and health outcomes.82   
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The purpose of the study presented in chapter four was to describe self-reported 
stress level, cognitive appraisal and coping among patients with HF, and to examine the 
association of cognitive appraisal and coping strategies with event-free survival. 
Our findings demonstrated that higher stress levels were associated with greater 
use of harm/loss cognitive appraisal which is considered a negative response associated 
with negative health outcomes. 70-72 In addition, we found that higher levels of stress and 
greater use of harm/loss cognitive appraisal were associated with avoidant emotional 
coping style, considered a negative coping style. 86 Furthermore, our findings suggest that 
avoidant emotional coping was a significant predictor of 6-month event-free survival in 
the unadjusted model, but it was not an independent predictor in the company of other 
variables. Also, we found that greater use of harm/loss cognitive appraisal predicted 
shorter event-free survival in HF. We conclude that the usual type of appraisal and 
coping used by patients with HF in response to stress should be avoided. Our findings 
demonstrated that cognitive appraisal and selected coping style plays a role in the stress 
response and health outcomes.70,83-87 Our findings where consistent with other studies that 
investigated stress, cognitive appraisals, coping styles, and health outcomes in HF 
population and other populations. 91,167-169 
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Implication 
Psychosocial factors are associated with many hazardous effects on mortality and 
morbidity rates of adults with HF. Until now, many of the health care providers do not 
pay much attention to those factors during delivering care and focus primarily on the 
pathophysiological aspect of HF. Thus, psychosocial factors remain an important 
problem that associated with HF and may contribute to the high comorbidity and 
mortality rates. The studies in this dissertation described and examine several of 
psychosocial factors that associated with HF. 
We found that comorbid anxiety and depression symptoms are a better predictor 
of death in HF patients than anxiety or depression alone controlling for disease severity, 
age, gender, and ethnicity. Our recommendation to improve health outcomes in patient 
with HF is to increase the awareness of health care providers to the importance of 
assessing and managing co-morbid symptoms of depression and anxiety. Furthermore, 
we recommend future studies that investigate and evaluate strategies regarding 
depression and anxiety symptoms screening and treatment in HF patients. 
Our findings also suggest no relationship between stress level and event-free 
survival or between stress level and salivary cortisol level in HF patients. However, our 
findings showed some indictors of a possible association between salivary cortisol level 
and event-free survival. We recommend before accepting any of these findings, future 
studies should be conducted with sample that have higher stress levels and larger size. 
Health care providers should also include cortisol level in their ordered lab studies when 
they provide care for HF patients. Cortisol level may be used as indicator for future 
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cardiac events. Thus, cortisol level needs to be monitored with developing strategies to 
control it in HF patients. 
Finally, we found that stress level is associated with harm/loss cognitive appraisal 
that associated with shorter event free survival in HF patients. In addition we found that 
harm/loss cognitive appraisal is associated with avoidant emotional coping that is 
associated with negative health outcomes and shorter event-free survival. Our 
recommendation to improve health outcomes in HF patients is to develop interventions to 
reduce stress levels among HF patients and to change their perception about their health 
condition. Furthermore, offering strategies to cope with HF that depend on cognitive 
restructuring especially for those who negatively appraise the stress of HF. This cognitive 
restructuring may lead them to a positive coping strategy that associated with better 
event-free survival. Thus, it is important for future studies in HF felid to address these 
psychosocial factors and try to develop management strategies to limits their possible 
hazardous effects.     
Copyright© Abdullah Subhi Alhurani 2016 
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